Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well...
Saved in:
Published in | Journal of autoimmunity Vol. 114; p. 102506 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines.
•Autoimmune and autoinflammatory conditions may be triggered by SARS-CoV-2.•Bystander activation and molecular mimicry could explain the appearance of these conditions.•In severe and critical patients, a cytokine storm syndrome (CSS) and a hypercoagulable state occur and may overlap.•CSS may promote the appearance of autoimmune and autoinflammatory-like conditions.•These observations should be considered in the current development of vaccines. |
---|---|
AbstractList | Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. • Autoimmune and autoinflammatory conditions may be triggered by SARS-CoV-2. • Bystander activation and molecular mimicry could explain the appearance of these conditions. • In severe and critical patients, a cytokine storm syndrome (CSS) and a hypercoagulable state occur and may overlap. • CSS may promote the appearance of autoimmune and autoinflammatory-like conditions. • These observations should be considered in the current development of vaccines. Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. •Autoimmune and autoinflammatory conditions may be triggered by SARS-CoV-2.•Bystander activation and molecular mimicry could explain the appearance of these conditions.•In severe and critical patients, a cytokine storm syndrome (CSS) and a hypercoagulable state occur and may overlap.•CSS may promote the appearance of autoimmune and autoinflammatory-like conditions.•These observations should be considered in the current development of vaccines. Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines.Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild in the majority, perhaps 80% of patients. The pathophysiological mechanisms resulting in minimal disease in this initial phase are not well known. In the remaining 20% of cases, the disease may become severe and/or critical. In most patients of this latter group, there is a phase characterized by the hyperresponsiveness of the immune system. A third phase corresponds to a state of hypercoagulability. Finally, in the fourth stage organ injury and failure occur. Appearance of autoinflammatory/autoimmune phenomena in patients with COVID-19 calls attention for the development of new strategies for the management of life-threatening conditions in critically ill patients. Antiphospholipid syndrome, autoimmune cytopenia, Guillain-Barré syndrome and Kawasaki disease have each been reported in patients with COVID-19. Here we present a scoping review of the relevant immunological findings in COVID-19 as well as the current reports about autoinflammatory/autoimmune conditions associated with the disease. These observations have crucial therapeutic implications since immunomodulatory drugs are at present the most likely best candidates for COVID-19 therapy. Clinicians should be aware of these conditions in patients with COVID-19, and these observations should be considered in the current development of vaccines. |
ArticleNumber | 102506 |
Author | Ridgway, William M. Acosta-Ampudia, Yeny Gershwin, M. Eric Novelli, Lucia Anaya, Juan-Manuel Ansari, Aftab A. Ramírez-Santana, Carolina Costanzo, Antonio De Santis, Maria Selmi, Carlo Rojas, Manuel Monsalve, Diana M. Rodríguez, Yhojan |
Author_xml | – sequence: 1 givenname: Yhojan surname: Rodríguez fullname: Rodríguez, Yhojan organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 2 givenname: Lucia surname: Novelli fullname: Novelli, Lucia organization: Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy – sequence: 3 givenname: Manuel surname: Rojas fullname: Rojas, Manuel organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 4 givenname: Maria surname: De Santis fullname: De Santis, Maria organization: Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy – sequence: 5 givenname: Yeny surname: Acosta-Ampudia fullname: Acosta-Ampudia, Yeny organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 6 givenname: Diana M. surname: Monsalve fullname: Monsalve, Diana M. organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 7 givenname: Carolina surname: Ramírez-Santana fullname: Ramírez-Santana, Carolina organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia – sequence: 8 givenname: Antonio surname: Costanzo fullname: Costanzo, Antonio organization: Dermatology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy – sequence: 9 givenname: William M. surname: Ridgway fullname: Ridgway, William M. organization: Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA – sequence: 10 givenname: Aftab A. surname: Ansari fullname: Ansari, Aftab A. organization: Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA – sequence: 11 givenname: M. Eric surname: Gershwin fullname: Gershwin, M. Eric email: megershwin@ucdavis.edu organization: Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA – sequence: 12 givenname: Carlo surname: Selmi fullname: Selmi, Carlo email: carlo.selmi@hunimed.eu organization: Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center (IRCCS), Rozzano, Milan, Italy – sequence: 13 givenname: Juan-Manuel surname: Anaya fullname: Anaya, Juan-Manuel email: juan.anaya@urosario.edu.co organization: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32563547$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9L7DAUxYMoOv75Ai6kSzedl6RJ2ooIw-hTQXCjbkOapJqxTTRJhfn2ptQnTxe6Ctyc372Hc3bBpnVWA3CI4BxBxP6s5isxxDmGeBxgCtkGmCFY07xGtNwEM1jVLK8IQjtgN4QVhAhRSrfBToEpKygpZ-ByMURnbNuJvhfR-XUmrMrEOOz7wepMOqtMNM6GTMQsPqWJdyF4J1Tm2mx5-3B9nqN6H2y1ogv64OPdA_d_L-6WV_nN7eX1cnGTS1rimLekQTIZLRmiVUMbSERBGGZVWQmJkZItrHRB6oYgWGBVkYbiRilZM1JLqVWxB86mvS9D02sltY1edPzFm174NXfC8K8_1jzxR_fGS1yzArO04PhjgXevgw6R9yZI3XXCajcEjklyVjBSjtKj_299HvmXXhLgSTBFottPCYJ8rIiv-FgRHyviU0UJqr5B0kQxJpz8mu5n9HRCdUr4zWjPgzTaplyM1zJy5czP-Mk3XHbGGim6Z73-DX4H2r2_mA |
CitedBy_id | crossref_primary_10_5662_wjm_v12_i4_200 crossref_primary_10_1016_j_jaut_2022_102898 crossref_primary_10_3390_cells10102545 crossref_primary_10_3389_fimmu_2021_686699 crossref_primary_10_1002_jmv_28067 crossref_primary_10_1007_s00256_021_03734_7 crossref_primary_10_1111_1744_9987_14004 crossref_primary_10_1007_s11030_021_10244_0 crossref_primary_10_3389_fimmu_2023_1183570 crossref_primary_10_4254_wjh_v13_i10_1367 crossref_primary_10_3390_jcm12247587 crossref_primary_10_3390_pathogens10030380 crossref_primary_10_1016_j_autrev_2021_102865 crossref_primary_10_1016_j_autrev_2021_102985 crossref_primary_10_3389_fimmu_2021_788368 crossref_primary_10_1007_s42399_020_00527_2 crossref_primary_10_3390_ijerph20054207 crossref_primary_10_1007_s00296_022_05149_6 crossref_primary_10_15448_1980_6108_2022_1_42436 crossref_primary_10_1002_ppul_25612 crossref_primary_10_1016_j_jaut_2021_102598 crossref_primary_10_1016_j_jaut_2020_102511 crossref_primary_10_1038_s41565_020_00810_2 crossref_primary_10_1515_revneuro_2023_0024 crossref_primary_10_1016_j_eucr_2022_102017 crossref_primary_10_1016_j_actatropica_2021_106013 crossref_primary_10_7759_cureus_19616 crossref_primary_10_4103_jfmpc_jfmpc_2246_22 crossref_primary_10_1080_00365513_2022_2079095 crossref_primary_10_2174_1871526522666220321153712 crossref_primary_10_7759_cureus_27583 crossref_primary_10_1016_j_transci_2022_103625 crossref_primary_10_3390_life11030182 crossref_primary_10_1016_j_jtauto_2024_100237 crossref_primary_10_1007_s12185_023_03589_9 crossref_primary_10_2174_2666145415666221004111511 crossref_primary_10_1016_j_jtauto_2021_100091 crossref_primary_10_1007_s10620_023_07967_5 crossref_primary_10_33920_MED_12_2102_07 crossref_primary_10_1080_01676830_2021_1962366 crossref_primary_10_1016_j_jtauto_2020_100069 crossref_primary_10_1111_1346_8138_16590 crossref_primary_10_1055_s_0042_1759778 crossref_primary_10_1016_j_transci_2021_103339 crossref_primary_10_3390_ijms232113656 crossref_primary_10_1007_s13139_021_00730_6 crossref_primary_10_3390_v15020400 crossref_primary_10_3892_mmr_2021_12498 crossref_primary_10_1093_ehjcr_ytab143 crossref_primary_10_36233_0507_4088_130 crossref_primary_10_1177_1535370220986785 crossref_primary_10_3389_fcimb_2024_1410282 crossref_primary_10_1111_liv_15044 crossref_primary_10_31146_1682_8658_ecg_206_10_163_168 crossref_primary_10_1002_ccr3_5237 crossref_primary_10_3899_jrheum_210226 crossref_primary_10_1016_j_clim_2021_108896 crossref_primary_10_1016_j_nrleng_2020_07_011 crossref_primary_10_1016_j_transci_2023_103729 crossref_primary_10_1007_s00705_023_05773_y crossref_primary_10_1111_ijd_15239 crossref_primary_10_1016_j_jaut_2022_102846 crossref_primary_10_21518_2079_701X_2020_17_66_73 crossref_primary_10_3390_ijms23031716 crossref_primary_10_1002_jmv_26921 crossref_primary_10_1080_13813455_2022_2080228 crossref_primary_10_1016_j_clim_2023_109882 crossref_primary_10_1177_09612033221098571 crossref_primary_10_3389_fimmu_2021_645013 crossref_primary_10_1007_s40265_020_01367_z crossref_primary_10_52547_johe_10_1_12 crossref_primary_10_2957_kanzo_65_58 crossref_primary_10_31260_RepertMedCir_01217372_1402 crossref_primary_10_5021_ad_24_001 crossref_primary_10_24835_1607_0763_1232 crossref_primary_10_1590_1806_9282_20210602 crossref_primary_10_22625_2072_6732_2022_14_4_26_37 crossref_primary_10_1136_annrheumdis_2021_220044 crossref_primary_10_1007_s00117_021_00907_2 crossref_primary_10_1016_j_ajg_2022_07_001 crossref_primary_10_3389_fpubh_2024_1371110 crossref_primary_10_1097_ACI_0000000000000888 crossref_primary_10_1016_j_jtauto_2025_100281 crossref_primary_10_1016_j_nano_2022_102604 crossref_primary_10_1051_mbcb_2021003 crossref_primary_10_3389_fendo_2021_805647 crossref_primary_10_3389_fphar_2022_973246 crossref_primary_10_4236_wjns_2021_112015 crossref_primary_10_1016_j_autneu_2022_103071 crossref_primary_10_23868_202012013 crossref_primary_10_3390_jcm12093190 crossref_primary_10_1016_j_molimm_2021_06_021 crossref_primary_10_1111_cts_13297 crossref_primary_10_1177_03000605241233450 crossref_primary_10_1186_s12985_023_01989_1 crossref_primary_10_4103_injr_injr_114_21 crossref_primary_10_1016_j_jaut_2021_102687 crossref_primary_10_1007_s12026_023_09371_7 crossref_primary_10_3390_vaccines9080815 crossref_primary_10_1093_infdis_jiaa485 crossref_primary_10_3389_fimmu_2025_1510770 crossref_primary_10_1093_infdis_jiab330 crossref_primary_10_1111_exd_14407 crossref_primary_10_5339_qmj_2021_65 crossref_primary_10_1186_s12879_022_07610_0 crossref_primary_10_1016_j_nrl_2020_07_013 crossref_primary_10_3889_oamjms_2021_6766 crossref_primary_10_1016_j_biopha_2020_110698 crossref_primary_10_1186_s12974_022_02454_6 crossref_primary_10_3389_fmolb_2020_557377 crossref_primary_10_1177_11206721221123780 crossref_primary_10_1007_s12020_021_02881_0 crossref_primary_10_3389_fmolb_2022_804109 crossref_primary_10_1016_j_mehy_2020_110345 crossref_primary_10_3390_ijms232314688 crossref_primary_10_1016_j_intimp_2022_109061 crossref_primary_10_3389_fmed_2021_754667 crossref_primary_10_3390_microorganisms10010153 crossref_primary_10_1093_bib_bbac056 crossref_primary_10_3389_fnhum_2021_656313 crossref_primary_10_3390_genes13040676 crossref_primary_10_2478_rir_2021_0004 crossref_primary_10_1038_s41467_021_25102_8 crossref_primary_10_1016_j_etap_2020_103520 crossref_primary_10_3390_antib11040068 crossref_primary_10_1016_j_aace_2023_04_006 crossref_primary_10_1016_j_cellsig_2021_110121 crossref_primary_10_7883_yoken_JJID_2021_281 crossref_primary_10_1007_s40265_020_01421_w crossref_primary_10_1016_j_jtauto_2021_100129 crossref_primary_10_1111_dth_14405 crossref_primary_10_1016_j_htct_2021_04_005 crossref_primary_10_3390_jcm12020601 crossref_primary_10_1016_j_jaut_2020_102592 crossref_primary_10_1159_000525562 crossref_primary_10_1007_s40744_022_00508_y crossref_primary_10_1016_j_jtauto_2021_100137 crossref_primary_10_1007_s10787_022_01047_2 crossref_primary_10_1136_bcr_2021_247022 crossref_primary_10_1055_s_0042_1758118 crossref_primary_10_3389_fimmu_2022_859550 crossref_primary_10_3390_genes12020154 crossref_primary_10_3389_fmmed_2022_1035290 crossref_primary_10_3390_jcm10020191 crossref_primary_10_37871_jbres1297 crossref_primary_10_3390_vaccines9111346 crossref_primary_10_1080_15569527_2021_1919138 crossref_primary_10_1021_acsomega_2c04589 crossref_primary_10_17816_brmma72051 crossref_primary_10_1080_1744666X_2021_1905526 crossref_primary_10_3390_jcm9124021 crossref_primary_10_1183_16000617_0197_2022 crossref_primary_10_1016_j_jaut_2020_102580 crossref_primary_10_4103_injr_injr_76_22 crossref_primary_10_1155_2022_2934171 crossref_primary_10_1016_j_jaut_2021_102616 crossref_primary_10_1016_j_jiph_2022_01_007 crossref_primary_10_7759_cureus_29076 crossref_primary_10_3389_fimmu_2021_705772 crossref_primary_10_3390_life13061252 crossref_primary_10_1093_milmed_usad446 crossref_primary_10_1016_j_ekir_2023_03_016 crossref_primary_10_1016_j_isci_2021_103115 crossref_primary_10_23736_S1825_859X_21_00104_3 crossref_primary_10_3389_fimmu_2021_720363 crossref_primary_10_1016_j_cca_2023_117742 crossref_primary_10_1080_1744666X_2022_2085561 crossref_primary_10_1542_pir_2020_002782 crossref_primary_10_35627_2219_5238_2021_335_2_70_74 crossref_primary_10_1002_jmv_27175 crossref_primary_10_3389_fimmu_2021_732913 crossref_primary_10_1007_s10067_022_06106_1 crossref_primary_10_1080_08923973_2021_1988102 crossref_primary_10_1007_s00251_021_01250_5 crossref_primary_10_1016_j_autrev_2021_102792 crossref_primary_10_1136_bcr_2021_243880 crossref_primary_10_1111_bjh_17079 crossref_primary_10_1093_jnen_nlad005 crossref_primary_10_3350_cmh_2022_0233 crossref_primary_10_1007_s00508_021_01867_2 crossref_primary_10_7759_cureus_41498 crossref_primary_10_1016_j_mehy_2021_110677 crossref_primary_10_1093_jleuko_qiae002 crossref_primary_10_1016_j_neurol_2022_11_009 crossref_primary_10_1016_j_lfs_2023_121531 crossref_primary_10_3390_v15102045 crossref_primary_10_3389_fimmu_2023_1308477 crossref_primary_10_1016_j_lfs_2022_121018 crossref_primary_10_1016_j_gaceta_2022_03_002 crossref_primary_10_18705_2782_3806_2023_3_2_46_56 crossref_primary_10_1080_08820139_2021_1876086 crossref_primary_10_1111_ijcp_14886 crossref_primary_10_3390_v13050932 crossref_primary_10_1016_j_compbiomed_2023_106855 crossref_primary_10_1172_JCI154886 crossref_primary_10_3389_fimmu_2022_985433 crossref_primary_10_3390_biomedicines9081003 crossref_primary_10_46497_ArchRheumatol_2024_10330 crossref_primary_10_1080_01635581_2021_1957128 crossref_primary_10_1038_s41598_022_15467_1 crossref_primary_10_14309_crj_0000000000000652 crossref_primary_10_3389_fneur_2021_657004 crossref_primary_10_1155_2022_1622160 crossref_primary_10_1101_cshperspect_a041157 crossref_primary_10_3390_vaccines10122073 crossref_primary_10_3389_fimmu_2021_719023 crossref_primary_10_47360_1995_4484_2021_5_30 crossref_primary_10_1016_j_mehy_2021_110538 crossref_primary_10_3390_medicina57030253 crossref_primary_10_3389_fimmu_2022_1052850 |
Cites_doi | 10.1007/s10072-020-04449-8 10.3201/eid1310.070576 10.1212/NXI.0000000000000741 10.1038/cmi.2017.142 10.2174/1389202916666141223220551 10.1016/S0140-6736(20)30868-0 10.5812/jjm.11014 10.1016/j.chom.2020.04.009 10.7554/eLife.57555 10.1016/j.autrev.2020.102554 10.1007/s00134-020-06062-x 10.1016/j.jinf.2020.04.017 10.1111/jns.12382 10.1016/j.chom.2020.04.017 10.1007/s12250-020-00207-4 10.1126/science.1140485 10.1016/j.cell.2020.02.052 10.4049/jimmunol.1101284 10.1172/JCI140200 10.1371/journal.pmed.0030297 10.1007/s10067-018-4209-9 10.1111/tan.13941 10.1186/s40425-018-0343-9 10.1016/j.berh.2012.07.002 10.3390/v11080762 10.1016/j.ijid.2020.03.013 10.1016/j.jaut.2019.06.012 10.1002/art.40071 10.1186/ar4193 10.4049/jimmunol.176.12.7278 10.1016/j.immuni.2020.06.001 10.1016/j.ebiom.2020.102763 10.1172/JCI200112173 10.1016/j.genm.2011.10.003 10.1016/j.cgh.2020.05.047 10.1038/s41423-018-0004-4 10.1016/S0140-6736(20)30183-5 10.3389/fpubh.2020.00152 10.55563/clinexprheumatol/xcdary 10.1097/01.md.0000157397.30055.c9 10.1056/NEJMc2007575 10.1038/s41577-020-0311-8 10.1016/j.clim.2020.108426 10.3389/fimmu.2019.00119 10.1016/S0140-6736(20)30980-6 10.1016/S2352-3026(20)30175-7 10.1161/CIRCULATIONAHA.120.048360 10.1073/pnas.2005615117 10.1089/jir.2011.0047 10.1371/journal.pone.0215665 10.1016/j.autrev.2014.01.058 10.1111/j.1365-2249.2005.02821.x 10.1056/NEJMoa2001017 10.1186/ar1208 10.3389/fimmu.2019.01532 10.1002/jmv.25866 10.1093/infdis/jiq136 10.1155/2013/981232 10.1136/ard.47.9.764 10.1038/s41423-020-0402-2 10.1016/j.autrev.2020.102556 10.2217/imt-2016-0020 10.1016/S0140-6736(20)31094-1 10.1111/j.1749-6632.1997.tb52078.x 10.1002/eji.200939444 10.1016/j.jaut.2011.10.003 10.1542/hpeds.2020-0123 10.1016/j.clim.2020.108480 10.1177/0961203319838063 10.1136/bmj.m2123 10.1159/000312628 10.1093/infdis/jiv380 10.1038/s41392-020-0148-4 10.1016/j.bbi.2020.04.074 10.1007/s12016-019-08747-8 10.1016/j.autrev.2012.07.018 10.1038/nri3190 10.1111/j.1600-065X.2009.00766.x 10.1038/s41591-020-0819-2 10.1016/j.jocn.2020.05.016 10.1001/jama.2020.8259 10.1016/j.clinph.2020.05.003 10.1007/s00134-020-05991-x 10.1128/JVI.06791-11 10.1136/annrheumdis-2020-217549 10.1007/s10067-010-1581-5 10.1212/WNL.0000000000009619 10.1016/j.jaut.2020.102442 10.1093/cid/ciaa248 10.1038/s41586-020-2012-7 10.1093/cid/ciaa638 10.1212/WNL.0000000000009921 10.4049/jimmunol.180.11.7112 10.1126/sciimmunol.abc3582 10.1182/blood-2006-10-043463 10.1136/annrheumdis-2020-217442 10.3389/fimmu.2020.00827 10.1038/s41591-020-0868-6 10.1016/j.berh.2014.03.002 10.2337/db07-1023 10.1038/s41564-020-0688-y 10.1016/S0140-6736(13)61048-X 10.1136/annrheumdis-2020-217362 10.1172/JCI138745 10.1186/s40249-020-00662-x 10.1016/j.cell.2020.04.026 10.1016/S1074-7613(02)00338-2 10.1056/NEJMc2010472 10.1056/NEJMc2011400 10.1111/imr.12109 10.1002/jmv.25715 10.1016/j.jaut.2018.10.012 10.1002/jmv.25801 10.1172/jci.insight.123158 10.1111/bjd.18203 10.1016/S2213-2600(20)30076-X 10.1007/s00281-017-0629-x 10.1016/S0140-6736(20)31103-X 10.4014/jmb.2003.03011 10.1172/JCI138554 10.1038/s41591-020-0897-1 10.1056/NEJMc2009191 10.1164/rccm.202003-0543OC 10.1007/s12026-013-8448-1 10.1016/S0140-6736(20)30628-0 10.1111/bjd.19163 10.3109/08916930903405891 10.1016/j.meegid.2020.104389 10.1093/infdis/jiaa150 10.1111/bjh.16850 10.1002/jmv.26138 10.1016/j.autrev.2020.102572 10.1016/j.ijid.2020.03.003 10.1016/j.autrev.2018.04.002 10.1016/j.semarthrit.2020.05.010 10.1038/nm.2028 10.1073/pnas.1614472114 10.1136/annrheumdis-2020-217562 10.1182/blood-2005-02-0456 10.1016/j.xcrm.2020.100040 10.1111/bjh.16794 10.1021/acschemneuro.0c00122 10.1177/1759720X13502919 10.1056/NEJMc2013656 10.1016/j.antiviral.2020.104762 10.1016/j.autrev.2020.102575 10.1111/imm.12929 10.1186/s12974-018-1246-x 10.1371/journal.pone.0045842 10.1111/bjh.16786 10.1016/j.jmii.2020.03.005 10.1016/j.imlet.2004.10.022 10.1016/j.idcr.2020.e00771 10.1136/annrheumdis-2013-203883 10.1007/s10067-015-2868-3 |
ContentType | Journal Article |
Copyright | 2020 Elsevier Ltd Copyright © 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd |
Copyright_xml | – notice: 2020 Elsevier Ltd – notice: Copyright © 2020 Elsevier Ltd. All rights reserved. – notice: 2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1016/j.jaut.2020.102506 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1095-9157 |
EndPage | 102506 |
ExternalDocumentID | PMC7296326 32563547 10_1016_j_jaut_2020_102506 S0896841120301281 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29J 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAAJQ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABJNI ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMG HMK HMO HVGLF HZ~ IHE J1W KOM LG5 LUGTX LZ5 M29 M41 MO0 N9A O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SES SEW SIN SPCBC SSH SSI SSZ T5K WUQ XPP Z5R ZGI ZMT ZU3 ~G- AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW EFLBG LCYCR RIG AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c572t-f4b1c50676158b5b04a34626878ac21dcf08e349b41032d84b52bddc9649cced3 |
IEDL.DBID | .~1 |
ISSN | 0896-8411 1095-9157 |
IngestDate | Thu Aug 21 14:07:24 EDT 2025 Tue Aug 05 10:26:25 EDT 2025 Thu Apr 03 07:06:30 EDT 2025 Thu Apr 24 23:00:55 EDT 2025 Tue Jul 01 03:24:10 EDT 2025 Fri Feb 23 02:47:55 EST 2024 Tue Aug 26 18:13:50 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 Autoimmunity SARS-CoV-2 Kawasaki disease Cytokine storm syndrome Vaccines Cytopenia Guillain-Barré syndrome Antiphospholipid syndrome |
Language | English |
License | Copyright © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c572t-f4b1c50676158b5b04a34626878ac21dcf08e349b41032d84b52bddc9649cced3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Authors contributed equally to this manuscript. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7296326 |
PMID | 32563547 |
PQID | 2415836476 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7296326 proquest_miscellaneous_2415836476 pubmed_primary_32563547 crossref_primary_10_1016_j_jaut_2020_102506 crossref_citationtrail_10_1016_j_jaut_2020_102506 elsevier_sciencedirect_doi_10_1016_j_jaut_2020_102506 elsevier_clinicalkey_doi_10_1016_j_jaut_2020_102506 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-11-01 |
PublicationDateYYYYMMDD | 2020-11-01 |
PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Journal of autoimmunity |
PublicationTitleAlternate | J Autoimmun |
PublicationYear | 2020 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Gutiérrez-Ortiz, Méndez, Rodrigo-Rey, San Pedro-Murillo, Bermejo-Guerrero, Gordo-Mañas, de Aragón-Gómez, Benito-León (bib26) 2020 Kanduc, Shoenfeld (bib176) 2020; 215 Behrens, Koretzky (bib125) 2017; 69 Bin Dhuban, Bartolucci, D'Hennezel, Piccirillo (bib146) 2019; 10 Moutsopoulos (bib135) 2020 Wouters, van der Veen, van de Putte, de Rooij (bib18) 1988; 47 Braun, Loyal, Frentsch, Wendisch, Georg, Kurth, Hippenstiel, Dingeldey, Kruse, Fauchere, Baysal, Mangold, Henze, Lauster, Mall, Beyer, Roehmel, Schmitz, Miltenyi, Mueller, Witzenrath, Suttorp, Kern, Reimer, Wenschuh, Drosten, Corman, Giesecke-Thiel, Sander, Thiel (bib97) 2020 Quintero, Amador-Patarroyo, Montoya-Ortiz, Rojas-Villarraga, Anaya (bib160) 2012; 38 Castiblanco, Anaya (bib194) 2015; 16 Zhou, Ren, Zhang, Zhong, Xiao, Jia, Guo, Yang, Wang, Jiang, Yang, Zhang, Li, Chen, Xu, Chen, Gao, Yang, Dong, Liu, Zhang, Wang, He, Jin, Li, Wang (bib73) 2020; 27 Emmi, Bettiol, Mattioli, Silvestri, Di Scala, Urban, Vaglio, Prisco (bib139) 2020; 19 Wu, Yang (bib124) 2020; 53 Cacoub, Terrier, Saadoun (bib13) 2014; 73 Zhang, Xiao, Zhang, Xia, Cao, Jiang, Chen, Ding, Zhao, Zhang, Wang, Zhao, Sun, Tian, Wu, Wu, Ma, Chen, Zhang, Xie, Yan, Zhou, Liu, Wang, Du, Qin, Gao, Qin, Xu, Zhang, Li, Zhang, Zhao, Li, Zhang (bib43) 2020; 382 Behrens (bib128) 2019 Scheidl, Canseco, Hadji‐Naumov, Bereznai (bib23) 2020 Meng-Yuan, Lin, Yue, Xiao-Sheng (bib63) 2020; 9 Rawlings, Schwartz, Jackson, Meyer-Bahlburg (bib56) 2012; 12 Rowley, Baker, Shulman, Rand, Tretiakova, Perlman, Garcia, Tajuddin, Fox, Huang, Ralphe, Takahashi, Flatow, Lin, Kalelkar, Soriano, Orenstein (bib185) 2011; 203 Ahn, Shin, Kim, Lee, Kim, Myoung, Kim, Kim (bib48) 2020; 30 Shamsizadeh, Ziaei Kajbaf, Razavi, Cheraghian (bib181) 2014; 7 Riphagen, Gomez, Gonzalez-Martinez, Wilkinson, Theocharis (bib38) 2020; 395 Ahmed, Khakwani, Venkatadasari, Horgan, Giles, Jobanputra, Lokare, Ewing, Paneesha, Murthy (bib33) 2020 Qin, Zhou, Hu, Zhang, Yang, Tao, Xie, Ma, Shang, Wang, Tian (bib71) 2020 Yang, Shen, Li, Yuan, Yang, Wang, Li, Li, Xing, Peng, Wei, Cao, Zheng, Wu, Zou, Li, Xu, Wang, Zhang, Zhang, Liu, Liu (bib82) 2020 Belhadjer, Méot, Bajolle, Khraiche, Legendre, Abakka, Auriau, Grimaud, Oualha, Beghetti, Wacker, Ovaert, Hascoet, Selegny, Malekzadeh-Milani, Maltret, Bosser, Giroux, Bonnemains, Bordet, Di Filippo, Mauran, Falcon-Eicher, Thambo, Lefort, Moceri, Houyel, Renolleau, Bonnet (bib41) 2020 Ramos-Casals, Loustaud-Ratti, De Vita, Zeher, Bosch, Toussirot, Medina, Rosas, Anaya, Font (bib14) 2005; 84 Rigamonti, Cittone, De Benedittis, Rizzi, Casciaro, Bellan, Sainaghi, Pirisi (bib140) 2020 Gorse, Donovan, Patel (bib171) 2020; 92 Sethuraman, Jeremiah, Ryo (bib5) 2020; 323 Toubiana, Poirault, Corsia, Bajolle, Fourgeaud, Angoulvant, Debray, Basmaci, Salvador, Biscardi, Frange, Chalumeau, Casanova, Cohen, Allali (bib42) 2020; 369 Harzallah, Debliquis, Drénou (bib44) 2020 Liu, Wei, Lin, Fang, Wang, Kwok, Tang, Nishiura, Peng, Tan, Wu, Cheung, Chan, Alvarez, Qin, Lackner, Perlman, Yuen, Chen (bib119) 2019; 4 (bib172) 2020 Bullard, Dust, Funk, Strong, Alexander, Garnett, Boodman, Bello, Hedley, Schiffman, Doan, Bastien, Li, Van Caeseele, Poliquin (bib174) 2020 Tanaka, Narazaki, Kishimoto (bib129) 2016; 8 Zhang, Qin, Deng, Ma, Guo, Guo, Hou, Wang, Zou, Sun, Ma, Hou (bib163) 2018; 15 Zhou, Yang, Wang, Hu, Zhang, Zhang, Si, Zhu, Li, Huang, Chen, Chen, Luo, Guo, Jiang, Liu, Chen, Shen, Wang, Zheng, Zhao, Chen, Deng, Liu, Yan, Zhan, Wang, Xiao, Shi (bib110) 2020; 579 Wang, Zhang, Zhang, He, Zhu (bib59) 2020 Rivera-Figueroa, Santos, Simpson, Garg (bib40) 2020 Davis, Hutcheson, Mohan (bib151) 2011; 31 Del Valle, Kim-schulze, Hsin-hui, Beckmann, Nirenberg, Wang, Lavin, Swartz, Madduri, Stock, Marron, Xie, Patel, van Oekelen, Rahman, Kovatch, Aberg, Schadt, Jagannath, Mazumdar, Charney, Firpo-Betancourt, Mendu, Jhang, Reich, Sigel, Cordon-Cardo, Feldmann, Parekh, Merad, Gnjatic (bib78) 2020 Lucchese, Flöel (bib175) 2020; 19 Naugler, Sakurai, Kim, Maeda, Kim, Elsharkawy, Karin (bib162) 2007; 317 Ceribelli, Motta, De Santis, Ansari, Ridgway, Gershwin, Selmi (bib193) 2020; 109 Zulfiqar, Lorenzo-Villalba, Hassler, Andrès (bib29) 2020; 382 Ferro F, Elefante, Baldini, Bartoloni, Puxeddu, Talarico, Mosca (bib190) 2020; 38 Schulert, Grom (bib141) 2014; 28 Thevarajan, Nguyen, Koutsakos, Druce, Caly, van de Sandt, Jia, Nicholson, Catton, Cowie, Tong, Lewin, Kedzierska (bib109) 2020; 26 Letko, Marzi, Munster (bib62) 2020; 5 Kahlenberg, Thacker, Berthier, Cohen, Kretzler, Kaplan (bib55) 2011; 187 Robbiani, Gaebler, Muecksch, Lorenzi, Wang, Cho, Agudelo, Barnes, Gazumyan, Finkin, Hagglof, Oliveira, Viant, Hurley, Hoffmann, Millard, Kost, Cipolla, Gordon, Bianchini, Chen, Ramos, Patel, Dizon, Shimeliovich, Mendoza, Hartweger, Nogueira, Pack, Horowitz, Schmidt, Weisblum, Michailidis, Ashbrook, Waltari, Pak, Huey-Tubman, Koranda, Hoffman, West, Rice, Hatziioannou, Bjorkman, Bieniasz, Caskey, Nussenzweig (bib116) 2020 Xu, Shi, Wang, Zhang, Huang, Zhang, Liu, Zhao, Liu, Zhu, Tai, Bai, Gao, Song, Xia, Dong, Zhao, Wang (bib101) 2020; 8 Dostál, Newkirk, Duffy, Palečková, Bošák, Černá, Žd’árský, Zvárová (bib17) 1997; 815 Verdoni, Mazza, Gervasoni, Martelli, Ruggeri, Ciuffreda, Bonanomi, D’Antiga (bib39) 2020; 395 Zang, Gomez Castro, McCune, Zeng, Rothlauf, Sonnek, Liu, Brulois, Wang, Greenberg, Diamond, Ciorba, Whelan, Ding (bib67) 2020; 5 Raucci, Mansour, Casillo, Saviano, Caso, Scarpa, Mascolo, Iqbal, Maione (bib179) 2020; 19 Baggio (bib156) 2017; 39 McGonagle, McDermott (bib50) 2006; 3 Xiong, Liu, Cao, Wang, Guo, Jiang, Guo, Hu, Yang, Tang, Wu, Lin, Zhang, Zhang, Shi, Liu, Zhou, Lan, Chen (bib105) 2020; 9 Long, Liu, Deng, Wu, Deng, Chen, Liao, Qiu, Lin, Cai, Wang, Hu, Ren, Tang, Xu, Yu, Mo, Gong, Zhang, Tian, Hu, Zhang, Xiang, Du, Liu, Lang, Luo, Wu, Cui, Zhou, Zhu, Wang, Xue, Li, Wang, Li, Wang, Niu, Yang, Tang, Zhang, Liu, Li, Zhang, Zhang, Liu, Yuan, Li, Hu, Chen, Huang (bib7) 2020 Lopez, Kim, Pandey, Huang, DeLoughery (bib31) 2020 Liu, Li, Liu, Liang, Wang, Wang, Li, Tong, Yi, Zhao, Xiong, Guo, Tian, Luo, Yao, Pang, Shen, Peng, Liu, Zhang, Wu, Xu, Lu, Wang, Weng, Han, Zhu, Zhou, Zhou, Chen, Ye, Zhu, Wang, Zhou, He, He, Jie, Wei, Zhang, Lu, Wang, Zhang, Li, Zhou, Wang, Dittmer, Lu, Hu, Yang, Zheng (bib80) 2020; 55 Fafi-Kremer, Bruel, Madec, Grant, Tondeur, Grzelak, Staropoli, Anna, Souque, Mutter, Collongues, Bolle, Velay, Lefebvre, Mielcarek, Meyer, Rey, Charneau, Hoen, De Seze, Schwartz, Fontanet (bib113) 2020 Bao, Deng, Gao, Xiao, Liu, Xue, Lv, Liu, Yu, Xu, Qi, Qu, Li, Xiang, Yu, Gong, Liu, Wang, Wang, Song, Zhao, Han, Zhao, Liu, Wei, Qin (bib167) 2020 Liu, Xu, Zhang, Xuan, Yan, Pan, Yu, Zhang (bib70) 2020; 95 Xu, Han, Li, Sun, Wang, Fu, Zhou, Zheng, Yang, Li, Zhang, Pan, Wei (bib130) 2020; 117 Jones, Mills, Suarez, Hogan, Yeh, Bradley Segal, Nguyen, Barsh, Maskatia, Mathew (bib37) 2020 Crayne, Albeituni, Nichols, Cron (bib145) 2019; 10 Novelli, Barbati, Ceccarelli, Perricone, Spinelli, Alessandri, Valesini, Perricone, Conti (bib98) 2019; 28 Du, Yuan (bib8) 2020 Wang, Yang, Li, Wen, Zhang (bib126) 2020 Murt, Eskazan, Yılmaz, Ozkan, Ar (bib32) 2020 Matsubara, Ichiyama, Furukawa (bib183) 2005; 141 Alberti, Beretta, Piatti, Karantzoulis, Piatti, Santoro, Viganò, Giovannelli, Pirro, Montisano, Appollonio, Ferrarese (bib19) 2020; 7 Khoruts, Fraser (bib93) 2005; 98 (bib58) 2013 Atkinson, Petersen (bib173) 2020; 395 Fu, Cheng, Wu (bib120) 2020 Sarzi-Puttini, Giorgi, Sirotti, Marotto, Ardizzone, Rizzardini, Antinori (bib192) 2020; 38 Tay, Poh, Rénia, MacAry, Ng (bib6) 2020; 20 Xiang, Wang, He, Peng, Yang, Zhang, Zhou, Ye, Ma, Li, Wei, Cai, Ma (bib111) 2020 Zeng, Li, Huang, Wu, Dong, Xu (bib106) 2020 Cameron, Kelvin, Leon, Cameron, Ran, Xu, Chu, Danesh, Fang, Li, Anderson, Couch, Paquette, Fomukong, Kistner, Lauchart, Rowe, Harrod, Jonsson, Kelvin (bib166) 2012; 7 Aguiar, Erkan (bib178) 2013; 5 Croft, So, Duan, Soroosh (bib99) 2009; 229 Sungnak, Huang, Bécavin, Berg, Queen, Litvinukova, Talavera-López, Maatz, Reichart, Sampaziotis, Worlock, Yoshida, Barnes (bib65) 2020; 26 Rojas, Rodríguez, Monsalve, Acosta-Ampudia, Camacho, Gallo, Rojas-Villarraga, Ramírez-Santana, Díaz-Coronado, Manrique, Mantilla, Shoenfeld, Anaya (bib121) 2020; 19 Ellinghaus, Degenhardt, Bujanda, Buti, Albillos, Invernizzi, Fernandez, Prati, Baselli, Asselta, Grimsrud, Milani, Aziz, Kassens, May, Wendorff, Wienbrandt, Uellendahl-Werth, Zheng, Yi, de Pablo, Chercoles, Palom, Garcia-Fernandez, Rodriguez-Frias, Zanella, Bandera, Protti, Aghemo, de Nalda, Biondi, Caballero-Garralda, Gori, Tanck, Latiano, Fracanzani, Peschuck, Julia, Pesenti, Voza, Jimenez, Mateos, Jimenez, Quereda, Angelini, Cea, Solier, Pestana, Sandoval, Paraboschi, Navas, Ceriotti, Martinelli-Boneschi, Peyvandi, Blasi, Tellez, Blanco-Grau, Grasselli, Costantino, Cardamone, Foti, Aneli, Kurihara, ElAbd, My, Martin, Erdmann, Ferrusquia-Acosta, Garcia-Etxebarria, Izquierdo-Sanchez, Bettini, Terranova, Moreira, Santoro, Scudeller, Mesonero, Roade, Schaefer, Carrabba, Riveiro Barciela, Basso, Valsecchi, Hernandez-Tejero, Acosta-Herrera, D\textquoterightAngio, Baldini, Cazzaniga, Schulzky, Cecconi, Wittig, Ciccarelli, Rodriguez-Gandia, Bocciolone, Miozzo, Braun, Martinez, Palmieri, Faverio, Preatoni, Bonfanti, Omodei, Tentorio, Castro, Rodrigues, Blandino Ortiz, Roca, Gualtierotti, Nieto, Badalamenti, Marsal, Matullo, Pelusi, Monzani, Wesse, Pumarola, Rimoldi, Bosari, Albrecht, Peter, Gomez, D\textquoterightAmato, Duga, Banales, Hov, Folseraas, Valenti, Franke, Karlsen (bib60) 2020 Sharmeen, Elghawy, Zarlasht, Yao (bib138) 2020 Zuo, Yalavarthi, Shi, Gockman, Zuo, Madison, Blair, Weber, Barnes, Egeblad, Woods, Kanthi, Knight (bib4) 2020 Doria, Zen, Bettio, Gatto, Bassi, Nalotto, Ghirardello, Iaccarino, Punzi (bib51) 2012; 12 Gerfaud-Valentin, Jamilloux, Iwaz, Sève (bib155) 2014; 13 Gray, Westerhof, MacLeod (bib95) 2018; 154 Zhao, Qin, Zhang, Li, Liang, Sun, Xu, Dai, Li, Zhang, Peng, Feng, Li, Hu, Xiang, Ogg, Ho, McMichael, Jin, Knight, Dong, Zhang (bib84) 2020 Xu, Sun, Nie, Li, Kong, Liang, Hou, Huang, Li, Ma, Peng, Gao, Sh Rivera-Figueroa (10.1016/j.jaut.2020.102506_bib40) 2020 Boyman (10.1016/j.jaut.2020.102506_bib90) 2009; 39 Wu (10.1016/j.jaut.2020.102506_bib124) 2020; 53 Castiblanco (10.1016/j.jaut.2020.102506_bib194) 2015; 16 Antoniou (10.1016/j.jaut.2020.102506_bib154) 2013 Fernandez-Cooke (10.1016/j.jaut.2020.102506_bib182) 2019; 14 Atkinson (10.1016/j.jaut.2020.102506_bib173) 2020; 395 Aguiar (10.1016/j.jaut.2020.102506_bib178) 2013; 5 Novelli (10.1016/j.jaut.2020.102506_bib98) 2019; 28 Toubiana (10.1016/j.jaut.2020.102506_bib42) 2020; 369 Wang (10.1016/j.jaut.2020.102506_bib108) 2020 Wang (10.1016/j.jaut.2020.102506_bib59) 2020 Braciale (10.1016/j.jaut.2020.102506_bib142) 2013; 255 Riphagen (10.1016/j.jaut.2020.102506_bib38) 2020; 395 Verdoni (10.1016/j.jaut.2020.102506_bib39) 2020; 395 Zhou (10.1016/j.jaut.2020.102506_bib110) 2020; 579 Chen (10.1016/j.jaut.2020.102506_bib169) 2020; 93 Schulze-Koops (10.1016/j.jaut.2020.102506_bib89) 2004; 6 Schulert (10.1016/j.jaut.2020.102506_bib141) 2014; 28 Knochelmann (10.1016/j.jaut.2020.102506_bib104) 2018; 15 Mehta (10.1016/j.jaut.2020.102506_bib132) 2020; 395 Cameron (10.1016/j.jaut.2020.102506_bib166) 2012; 7 Letko (10.1016/j.jaut.2020.102506_bib62) 2020; 5 Cantini (10.1016/j.jaut.2020.102506_bib49) 2020 Bomhof (10.1016/j.jaut.2020.102506_bib34) 2020 Gorse (10.1016/j.jaut.2020.102506_bib171) 2020; 92 Ellinghaus (10.1016/j.jaut.2020.102506_bib60) 2020 Zhang (10.1016/j.jaut.2020.102506_bib163) 2018; 15 Xiang (10.1016/j.jaut.2020.102506_bib111) 2020 (10.1016/j.jaut.2020.102506_bib58) 2013 Bin Dhuban (10.1016/j.jaut.2020.102506_bib146) 2019; 10 Perrone (10.1016/j.jaut.2020.102506_bib131) 2020 Ruan (10.1016/j.jaut.2020.102506_bib3) 2020; 46 Blanco-Melo (10.1016/j.jaut.2020.102506_bib76) 2020; 181 Ceribelli (10.1016/j.jaut.2020.102506_bib193) 2020; 109 Shimabukuro-Vornhagen (10.1016/j.jaut.2020.102506_bib127) 2018; 6 Du (10.1016/j.jaut.2020.102506_bib68) 2020; 201 Meng-Yuan (10.1016/j.jaut.2020.102506_bib63) 2020; 9 Mihai (10.1016/j.jaut.2020.102506_bib136) 2020; 79 Roussou (10.1016/j.jaut.2020.102506_bib159) 2011; 30 Liblau (10.1016/j.jaut.2020.102506_bib103) 2002; 17 Arnaud (10.1016/j.jaut.2020.102506_bib25) 2020; 131 Helms (10.1016/j.jaut.2020.102506_bib46) 2020; 46 Virani (10.1016/j.jaut.2020.102506_bib21) 2020; 20 Del Valle (10.1016/j.jaut.2020.102506_bib78) 2020 Harzallah (10.1016/j.jaut.2020.102506_bib44) 2020 Bullard (10.1016/j.jaut.2020.102506_bib174) 2020 Khoruts (10.1016/j.jaut.2020.102506_bib93) 2005; 98 Vojdani (10.1016/j.jaut.2020.102506_bib177) 2020; 217 WHO (10.1016/j.jaut.2020.102506_bib2) 2020 Son (10.1016/j.jaut.2020.102506_bib186) 2020; 369 Sharmeen (10.1016/j.jaut.2020.102506_bib138) 2020 Lucchese (10.1016/j.jaut.2020.102506_bib175) 2020; 19 Costello (10.1016/j.jaut.2020.102506_bib189) 2020 Scheidl (10.1016/j.jaut.2020.102506_bib23) 2020 Shi (10.1016/j.jaut.2020.102506_bib81) 2020 Ahn (10.1016/j.jaut.2020.102506_bib48) 2020; 30 Zhao (10.1016/j.jaut.2020.102506_bib84) Rowley (10.1016/j.jaut.2020.102506_bib185) 2011; 203 Liu (10.1016/j.jaut.2020.102506_bib80) 2020; 55 Bloch (10.1016/j.jaut.2020.102506_bib117) 2020; 130 Kahlenberg (10.1016/j.jaut.2020.102506_bib55) 2011; 187 Sbidian (10.1016/j.jaut.2020.102506_bib57) 2019; 181 Zheng (10.1016/j.jaut.2020.102506_bib150) 2008; 180 Crayne (10.1016/j.jaut.2020.102506_bib145) 2019; 10 Mazzoni (10.1016/j.jaut.2020.102506_bib75) 2020 Thevarajan (10.1016/j.jaut.2020.102506_bib109) 2020; 26 Xu (10.1016/j.jaut.2020.102506_bib112) 2020 Fafi-Kremer (10.1016/j.jaut.2020.102506_bib113) 2020 Baggio (10.1016/j.jaut.2020.102506_bib156) 2017; 39 Ferro F (10.1016/j.jaut.2020.102506_bib190) 2020; 38 Crosslin (10.1016/j.jaut.2020.102506_bib158) 2011; 8 Liu (10.1016/j.jaut.2020.102506_bib77) 2020 Coen (10.1016/j.jaut.2020.102506_bib22) 2020 Franco (10.1016/j.jaut.2020.102506_bib184) 2010; 43 Tanaka (10.1016/j.jaut.2020.102506_bib129) 2016; 8 Naugler (10.1016/j.jaut.2020.102506_bib162) 2007; 317 Zulfiqar (10.1016/j.jaut.2020.102506_bib29) 2020; 382 Zhang (10.1016/j.jaut.2020.102506_bib69) 2020 Chen (10.1016/j.jaut.2020.102506_bib153) 2013; 15 Clay (10.1016/j.jaut.2020.102506_bib168) 2012; 86 Sarzi-Puttini (10.1016/j.jaut.2020.102506_bib192) 2020; 38 Ortona (10.1016/j.jaut.2020.102506_bib161) 2015; 1 Singh (10.1016/j.jaut.2020.102506_bib149) 2010 Wu (10.1016/j.jaut.2020.102506_bib170) 2007; 13 Zhou (10.1016/j.jaut.2020.102506_bib73) 2020; 27 Fu (10.1016/j.jaut.2020.102506_bib120) 2020 Pacheco (10.1016/j.jaut.2020.102506_bib11) 2019; 103 Toscano (10.1016/j.jaut.2020.102506_bib20) 2020 Mathew (10.1016/j.jaut.2020.102506_bib85) 2020 Zeng (10.1016/j.jaut.2020.102506_bib106) 2020 GeurtsvanKessel (10.1016/j.jaut.2020.102506_bib114) 2020 Puelles (10.1016/j.jaut.2020.102506_bib64) 2020 Dostál (10.1016/j.jaut.2020.102506_bib17) 1997; 815 Patterson (10.1016/j.jaut.2020.102506_bib83) 2020 Behrens (10.1016/j.jaut.2020.102506_bib125) 2017; 69 Quintero (10.1016/j.jaut.2020.102506_bib160) 2012; 38 Rawlings (10.1016/j.jaut.2020.102506_bib56) 2012; 12 Teuwen (10.1016/j.jaut.2020.102506_bib87) 2020 Qin (10.1016/j.jaut.2020.102506_bib71) 2020 Zheng (10.1016/j.jaut.2020.102506_bib72) 2020; 17 Ottaviani (10.1016/j.jaut.2020.102506_bib27) 2020; 41 Maeda (10.1016/j.jaut.2020.102506_bib91) 2005; 106 Long (10.1016/j.jaut.2020.102506_bib7) 2020 Sungnak (10.1016/j.jaut.2020.102506_bib65) 2020; 26 Ramos-Casals (10.1016/j.jaut.2020.102506_bib143) 2014; 383 Li (10.1016/j.jaut.2020.102506_bib152) 2020; 58 Theofilopoulos (10.1016/j.jaut.2020.102506_bib94) 2001; 108 Liu (10.1016/j.jaut.2020.102506_bib119) 2019; 4 Xu (10.1016/j.jaut.2020.102506_bib101) 2020; 8 van de Veerdonk (10.1016/j.jaut.2020.102506_bib88) 2020; 9 Smatti (10.1016/j.jaut.2020.102506_bib9) 2019; 11 Luo (10.1016/j.jaut.2020.102506_bib47) 2020 Zhou (10.1016/j.jaut.2020.102506_bib74) 2020 Lokman (10.1016/j.jaut.2020.102506_bib61) 2020 Raucci (10.1016/j.jaut.2020.102506_bib179) 2020; 19 Seydoux (10.1016/j.jaut.2020.102506_bib118) 2020 Sethuraman (10.1016/j.jaut.2020.102506_bib5) 2020; 323 Zuo (10.1016/j.jaut.2020.102506_bib4) 2020 Shamsizadeh (10.1016/j.jaut.2020.102506_bib181) 2014; 7 Moutsopoulos (10.1016/j.jaut.2020.102506_bib135) 2020 Gutiérrez-Ortiz (10.1016/j.jaut.2020.102506_bib26) 2020 Juliao Caamaño (10.1016/j.jaut.2020.102506_bib24) 2020 Zang (10.1016/j.jaut.2020.102506_bib67) 2020; 5 Davis (10.1016/j.jaut.2020.102506_bib151) 2011; 31 Wouters (10.1016/j.jaut.2020.102506_bib18) 1988; 47 Lazarian (10.1016/j.jaut.2020.102506_bib30) 2020 Sanderson (10.1016/j.jaut.2020.102506_bib15) 2017; 114 Jones (10.1016/j.jaut.2020.102506_bib37) 2020 Rigamonti (10.1016/j.jaut.2020.102506_bib140) 2020 Gerfaud-Valentin (10.1016/j.jaut.2020.102506_bib155) 2014; 13 Bao (10.1016/j.jaut.2020.102506_bib167) 2020 Murt (10.1016/j.jaut.2020.102506_bib32) 2020 Tay (10.1016/j.jaut.2020.102506_bib6) 2020; 20 Zhang (10.1016/j.jaut.2020.102506_bib43) 2020; 382 Belhadjer (10.1016/j.jaut.2020.102506_bib41) 2020 Generali (10.1016/j.jaut.2020.102506_bib52) 2018; 17 Yang (10.1016/j.jaut.2020.102506_bib82) 2020 Anna Ruggieri (10.1016/j.jaut.2020.102506_bib164) 2020; 6 Tan (10.1016/j.jaut.2020.102506_bib92) 2020; 5 Nathan (10.1016/j.jaut.2020.102506_bib36) 2020; 395 Chen (10.1016/j.jaut.2020.102506_bib35) 2020 Suthar (10.1016/j.jaut.2020.102506_bib115) 2020 Ramos-Casals (10.1016/j.jaut.2020.102506_bib14) 2005; 84 McGonagle (10.1016/j.jaut.2020.102506_bib50) 2006; 3 Huang (10.1016/j.jaut.2020.102506_bib123) 2020; 395 Du (10.1016/j.jaut.2020.102506_bib8) 2020 Jin (10.1016/j.jaut.2020.102506_bib165) 2020; 8 O'Sullivan (10.1016/j.jaut.2020.102506_bib147) 2006; 176 Joyner (10.1016/j.jaut.2020.102506_bib122) 2020 Lopez (10.1016/j.jaut.2020.102506_bib31) 2020 Devarajan (10.1016/j.jaut.2020.102506_bib96) 2013; 57 Alberti (10.1016/j.jaut.2020.102506_bib19) 2020; 7 Xu (10.1016/j.jaut.2020.102506_bib130) 2020; 117 Gray (10.1016/j.jaut.2020.102506_bib95) 2018; 154 Kanduc (10.1016/j.jaut.2020.102506_bib176) 2020; 215 Ahmed (10.1016/j.jaut.2020.102506_bib33) 2020 Touret (10.1016/j.jaut.2020.102506_bib191) 2020; 177 Ghiringhelli (10.1016/j.jaut.2020.102506_bib54) 2009; 15 Caso (10.1016/j.jaut.2020.102506_bib53) 2018; 37 Dinkin (10.1016/j.jaut.2020.102506_bib28) 2020 Chu (10.1016/j.jaut.2020.102506_bib107) 2016; 213 Diao (10.1016/j.jaut.2020.102506_bib79) 2020; 11 Giamarellos-Bourboulis (10.1016/j.jaut.2020.102506_bib133) 2020; 27 Channappanavar (10.1016/j.jaut.2020.102506_bib86) 2017; 39 (10.1016/j.jaut.2020.102506_bib172) 2020 Pouchot (10.1016/j.jaut.2020.102506_bib148) 2012; 26 Deane (10.1016/j.jaut.2020.102506_bib144) 2010; 153 Rojas (10.1016/j.jaut.2020.102506_bib10) 2018; 95 Wang (10.1016/j.jaut.2020.102506_bib102) 2020; 221 Robbiani (10.1016/j.jaut.2020.102506_bib116) 2020 Liu (10.1016/j.jaut.2020.102506_bib70) 2020; 95 Chen (10.1016/j.jaut.2020.102506_bib16) 2015; 34 Behrens (10.1016/j.jaut.2020.102506_bib128) 2019 Doria (10.1016/j.jaut.2020.102506_bib51) 2012; 12 Duret (10.1016/j.jaut.2020.102506_bib134) 2020 Filippi (10.1016/j.jaut.2020.102506_bib12) 2008; 57 Bowles (10.1016/j.jaut.2020.102506_bib45) 2020 Matsubara (10.1016/j.jaut.2020.102506_bib183) 2005; 141 Rojas (10.1016/j.jaut.2020.102506_bib121) 2020; 19 Xiong (10.1016/j.jaut.2020.102506_bib105) 2020; 9 Cacoub (10.1016/j.jaut.2020.102506_bib13) 2014; 73 Emmi (10.1016/j.jaut.2020.102506_bib139) 2020; 19 Hoffmann (10.1016/j.jaut.2020.102506_bib66) 2020; 181 Zhu (10.1016/j.jaut.2020.102506_bib100) 2007; 109 Guilpain (10.1016/j.jaut.2020.102506_bib137) 2020 Baig (10.1016/j.jaut.2020.102506_bib188) 2020; 11 Zhu (10.1016/j.jaut.2020.102506_bib1) 2020; 382 Galván Casas (10.1016/j.jaut.2020.102506_bib180) 2020 Croft (10.1016/j.jaut.2020.102506_bib99) 2009; 229 Wang (10.1016/j.jaut.2020.102506_bib126) 2020 Rodríguez (10.1016/j.jaut.2020.102506_bib187) 2018; 15 Braun (10.1016/j.jaut.2020.102506_bib97) 2020 Angela Tincani (10.1016/j.jaut.2020.102506_bib157) 2018; 4 |
References_xml | – volume: 14 year: 2019 ident: bib182 article-title: Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group publication-title: PloS One – volume: 141 start-page: 381 year: 2005 end-page: 387 ident: bib183 article-title: Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease publication-title: Clin. Exp. Immunol. – year: 2020 ident: bib64 article-title: Multiorgan and renal tropism of SARS-CoV-2 publication-title: N. Engl. J. Med. – year: 2020 ident: bib7 article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19 publication-title: Nat. Med. – year: 2020 ident: bib26 article-title: Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 publication-title: Neurology – year: 2013 ident: bib58 publication-title: Autoimmunity: from Bench to Bedside – year: 2020 ident: bib189 article-title: Cranial neuropathies and COVID-19: neurotropism and autoimmunity publication-title: Neurology – volume: 177 start-page: 104762 year: 2020 ident: bib191 article-title: Of chloroquine and COVID-19 publication-title: Antivir. Res. – volume: 15 start-page: R39 year: 2013 ident: bib153 article-title: Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease publication-title: Arthritis Res. Ther. – volume: 19 start-page: 102575 year: 2020 ident: bib139 article-title: SARS-CoV-2 infection among patients with systemic autoimmune diseases publication-title: Autoimmun. Rev. – volume: 19 start-page: 102554 year: 2020 ident: bib121 article-title: Convalescent plasma in Covid-19: possible mechanisms of action publication-title: Autoimmun. Rev. – start-page: 1 year: 2020 end-page: 3 ident: bib87 article-title: COVID-19: the vasculature unleashed publication-title: Nat. Rev. Immunol. – year: 2020 ident: bib120 article-title: Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools publication-title: Virol. Sin. – volume: 3 start-page: e297 year: 2006 ident: bib50 article-title: A proposed classification of the immunological diseases publication-title: PLoS Med. – volume: 131 start-page: 1652 year: 2020 end-page: 1654 ident: bib25 article-title: Post SARS-CoV-2 guillain-barré syndrome publication-title: Clin. Neurophysiol. – volume: 20 year: 2020 ident: bib21 article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 infection publication-title: IDCases – volume: 109 start-page: 102442 year: 2020 ident: bib193 article-title: Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy publication-title: J. Autoimmun. – volume: 7 year: 2012 ident: bib166 article-title: Lack of innate Interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model publication-title: PloS One – volume: 395 start-page: 1339 year: 2020 end-page: 1340 ident: bib173 article-title: SARS-CoV-2 shedding and infectivity publication-title: Lancet – volume: 19 start-page: 102556 year: 2020 ident: bib175 article-title: Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons publication-title: Autoimmun. Rev. – volume: 103 start-page: 102301 year: 2019 ident: bib11 article-title: Bystander activation and autoimmunity publication-title: J. Autoimmun. – volume: 57 start-page: 2863 year: 2008 end-page: 2871 ident: bib12 article-title: Viral trigger for type 1 diabetes: pros and cons publication-title: Diabetes – year: 2020 ident: bib82 article-title: Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome publication-title: MedRxiv – volume: 815 start-page: 334 year: 1997 end-page: 337 ident: bib17 article-title: Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus publication-title: Ann. N. Y. Acad. Sci. – volume: 10 year: 2019 ident: bib145 article-title: The immunology of macrophage activation syndrome publication-title: Front. Immunol. – volume: 5 start-page: 33 year: 2020 ident: bib92 article-title: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study publication-title: Signal Transduct. Target. Theroy – volume: 5 start-page: 305 year: 2013 end-page: 314 ident: bib178 article-title: Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease publication-title: Ther. Adv. Musculoskelet. Disease – volume: 108 start-page: 335 year: 2001 end-page: 340 ident: bib94 article-title: T cell homeostasis and systemic autoimmunity publication-title: J. Clin. Invest. – volume: 382 start-page: e38 year: 2020 ident: bib43 article-title: Coagulopathy and antiphospholipid antibodies in patients with covid-19 publication-title: N. Engl. J. Med. – year: 2020 ident: bib134 article-title: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept publication-title: Ann. Rheum. Dis. – volume: 12 start-page: 282 year: 2012 end-page: 294 ident: bib56 article-title: Integration of B cell responses through Toll-like receptors and antigen receptors publication-title: Nat. Rev. Immunol. – year: 2020 ident: bib83 article-title: Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19 publication-title: MedRxiv – volume: 39 start-page: 196 year: 2017 end-page: 198 ident: bib156 article-title: Gender Medicine: a interdisciplinary approach to medicine publication-title: G. Ital. Med. Lav. Ergon. – year: 2020 ident: bib34 article-title: COVID-19-associated immune thrombocytopenia publication-title: Br. J. Haematol. – volume: 10 start-page: 1 year: 2019 end-page: 13 ident: bib146 article-title: Signaling through gp130 compromises suppressive function in human FOXP3+ regulatory T cells publication-title: Front. Immunol. – year: 2020 ident: bib140 article-title: Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study publication-title: Clin. Gastroenterol. Hepatol. – volume: 28 start-page: 621 year: 2019 end-page: 628 ident: bib98 article-title: CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients publication-title: Lupus – volume: 382 start-page: e43 year: 2020 ident: bib29 article-title: Immune thrombocytopenic purpura in a patient with covid-19 publication-title: N. Engl. J. Med. – volume: 46 start-page: 1089 year: 2020 end-page: 1098 ident: bib46 article-title: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study publication-title: Intensive Care Med. – year: 2020 ident: bib23 article-title: Guillain‐Barre syndrome during SARS‐CoV ‐2 pandemic: a case report and review of recent literature publication-title: J. Peripher. Nerv. Syst. – volume: 17 start-page: 533 year: 2020 end-page: 535 ident: bib72 article-title: Functional exhaustion of antiviral lymphocytes in COVID-19 patients publication-title: Cell. Mol. Immunol. – volume: 8 start-page: 152 year: 2020 ident: bib165 article-title: Gender differences in patients with COVID-19: focus on severity and mortality publication-title: Front. Public. Health – volume: 37 start-page: 2305 year: 2018 end-page: 2321 ident: bib53 article-title: From autoinflammation to autoimmunity: old and recent findings publication-title: Clin. Rheumatol. – volume: 16 start-page: 47 year: 2015 end-page: 59 ident: bib194 article-title: Genetics and vaccines in the era of personalized medicine publication-title: Curr. Genom. – volume: 15 start-page: 458 year: 2018 end-page: 469 ident: bib104 article-title: When worlds collide: Th17 and Treg cells in cancer and autoimmunity publication-title: Cell. Mol. Immunol. – volume: 43 start-page: 317 year: 2010 end-page: 324 ident: bib184 article-title: Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease publication-title: Autoimmunity – volume: 58 start-page: 71 year: 2020 end-page: 81 ident: bib152 article-title: Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease publication-title: Clin. Rev. Allergy Immunol. – volume: 17 start-page: 1 year: 2002 end-page: 6 ident: bib103 article-title: Autoreactive CD8 T cells in organ-specific autoimmunity publication-title: Immunity – volume: 395 start-page: 497 year: 2020 end-page: 506 ident: bib123 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet – volume: 323 start-page: 2249 year: 2020 end-page: 2251 ident: bib5 article-title: Interpreting diagnostic tests for SARS-CoV-2 publication-title: J. Am. Med. Assoc. – volume: 12 start-page: 22 year: 2012 end-page: 30 ident: bib51 article-title: Autoinflammation and autoimmunity: bridging the divide publication-title: Autoimmun. Rev. – year: 2020 ident: bib84 article-title: Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease, JCI Insight – volume: 98 start-page: 23 year: 2005 end-page: 31 ident: bib93 article-title: A causal link between lymphopenia and autoimmunity publication-title: Immunol. Lett. – year: 2020 ident: bib20 article-title: Guillain–barré syndrome associated with SARS-CoV-2 publication-title: N. Engl. J. Med. – start-page: 26138 year: 2020 ident: bib32 article-title: COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature publication-title: J. Med. Virol. – volume: 109 start-page: 4882 year: 2007 end-page: 4889 ident: bib100 article-title: CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype publication-title: Blood – volume: 369 year: 2020 ident: bib42 article-title: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study publication-title: BMJ – volume: 53 start-page: 368 year: 2020 end-page: 370 ident: bib124 article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib publication-title: J. Microbiol. Immunol. Infect. – year: 2020 ident: bib180 article-title: Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases publication-title: Br. J. Dermatol. – year: 2020 ident: bib44 article-title: Lupus anticoagulant is frequent in patients with Covid‐19 publication-title: J. Thromb. Haemostasis – year: 2020 ident: bib77 article-title: Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury publication-title: Natl. Sci. Rev. – year: 2020 ident: bib8 article-title: Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis publication-title: J. Med. Virol. – volume: 69 start-page: 1135 year: 2017 end-page: 1143 ident: bib125 article-title: Review: cytokine storm syndrome: looking toward the precision medicine era publication-title: Arthritis Rheum. – volume: 176 start-page: 7278 year: 2006 end-page: 7287 ident: bib147 article-title: IL-1β breaks tolerance through expansion of CD25 + effector T cells publication-title: J. Immunol. – year: 2020 ident: bib41 article-title: Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic publication-title: Circulation – volume: 1 start-page: 45 year: 2015 end-page: 50 ident: bib161 article-title: Sex hormones and gender disparity in immunity and autoimmunity publication-title: Italy J. Gender-Specifi c Med. – volume: 86 start-page: 4234 year: 2012 end-page: 4244 ident: bib168 article-title: Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge publication-title: J. Virol. – volume: 181 start-page: 1036 year: 2020 end-page: 1045.e9 ident: bib76 article-title: Imbalanced host response to SARS-CoV-2 drives development of COVID-19 publication-title: Cell – start-page: 1 year: 2020 end-page: 29 ident: bib131 article-title: Protocol Title : " Multicenter Study on the Efficacy and Tolerability of Tocilizumab in the Treatment of Patients with COVID-19 Pneumonia – year: 2020 ident: bib40 article-title: Incomplete Kawasaki Disease in a Child with Covid-19 – volume: 47 start-page: 764 year: 1988 end-page: 767 ident: bib18 article-title: Adult onset Still's disease and viral infections publication-title: Ann. Rheum. Dis. – volume: 13 start-page: 1562 year: 2007 end-page: 1564 ident: bib170 article-title: Duration of antibody responses after severe acute respiratory syndrome publication-title: Emerg. Infect. Dis. – volume: 9 start-page: 45 year: 2020 ident: bib63 article-title: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues publication-title: Infect. Disease Poverty. – volume: 229 start-page: 173 year: 2009 end-page: 191 ident: bib99 article-title: The significance of OX40 and OX40L to T-cell biology and immune disease publication-title: Immunol. Rev. – start-page: 2 year: 2020 end-page: 4 ident: bib108 article-title: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion publication-title: Cell. Mol. Immunol. – year: 2020 ident: bib60 article-title: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis publication-title: MedRxiv – volume: 213 start-page: 904 year: 2016 end-page: 914 ident: bib107 article-title: Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways publication-title: J. Infect. Dis. – volume: 181 start-page: 271 year: 2020 end-page: 280 ident: bib66 article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor publication-title: Cell – year: 2020 ident: bib172 article-title: Findings from Investigation and Analysis of Re-positive Cases – volume: 20 start-page: 363 year: 2020 end-page: 374 ident: bib6 article-title: The trinity of COVID-19: immunity, inflammation and intervention publication-title: Nat. Rev. Immunol. – volume: 130 start-page: 2757 year: 2020 end-page: 2765 ident: bib117 article-title: Deployment of convalescent plasma for the prevention and treatment of COVID-19 publication-title: J. Clin. Invest. – year: 2020 ident: bib115 article-title: Rapid generation of neutralizing antibody responses in COVID-19 patients publication-title: Cell Rep. Med. – year: 2020 ident: bib37 article-title: COVID-19 and Kawasaki disease: novel virus and novel case publication-title: Hosp. Pediatr. – volume: 95 start-page: 183 year: 2020 end-page: 191 ident: bib70 article-title: Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression publication-title: Int. J. Infect. Dis. – volume: 8 start-page: 420 year: 2020 end-page: 422 ident: bib101 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir. Med. – year: 2020 ident: bib137 article-title: Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia publication-title: Ann. Rheum. Dis. – year: 2020 ident: bib31 article-title: Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia publication-title: Br. J. Haematol. – volume: 6 start-page: 49 year: 2020 end-page: 50 ident: bib164 article-title: Gender differences in COVID-19: some open questions publication-title: Italy. J. Gender-Specific Med. – volume: 382 start-page: 727 year: 2020 end-page: 733 ident: bib1 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: N. Engl. J. Med. – volume: 30 start-page: 313 year: 2020 end-page: 324 ident: bib48 article-title: Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19) publication-title: J. Microbiol. Biotechnol. – volume: 30 start-page: 121 year: 2011 end-page: 127 ident: bib159 article-title: Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides publication-title: Clin. Rheumatol. – volume: 15 start-page: 206 year: 2018 ident: bib163 article-title: The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation publication-title: J. Neuroinflammation – volume: 317 start-page: 121 year: 2007 end-page: 124 ident: bib162 article-title: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production publication-title: Science – year: 2020 ident: bib118 article-title: Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation publication-title: Immunity – volume: 31 start-page: 781 year: 2011 end-page: 789 ident: bib151 article-title: The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus publication-title: J. Interferon Cytokine Res. – volume: 11 start-page: 762 year: 2019 ident: bib9 article-title: Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms publication-title: Viruses – year: 2020 ident: bib22 article-title: Guillain-Barré syndrome as a complication of SARS-CoV-2 infection publication-title: Brain Behav. Immun. – year: 2010 ident: bib149 article-title: Tocilizumab for rheumatoid arthritis publication-title: Cochrane Database Syst. Rev. – volume: 93 start-page: 297 year: 2020 end-page: 299 ident: bib169 article-title: Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report publication-title: Int. J. Infect. Dis. – year: 2020 ident: bib81 article-title: Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China publication-title: MedRxiv – volume: 57 start-page: 12 year: 2013 end-page: 22 ident: bib96 article-title: Autoimmune effector memory T cells: the bad and the good publication-title: Immunol. Res. – year: 2020 ident: bib116 article-title: Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals publication-title: BioRxiv – year: 2020 ident: bib74 article-title: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients publication-title: Natl. Sci. Rev. – volume: 7 start-page: e741 year: 2020 ident: bib19 article-title: Guillain-Barré syndrome related to COVID-19 infection publication-title: Neurol. Neuroimmunol. Neuroinflammation. – volume: 215 start-page: 108426 year: 2020 ident: bib176 article-title: On the molecular determinants of the SARS-CoV-2 attack publication-title: Clin. Immunol. – volume: 8 start-page: 365 year: 2011 end-page: 371 ident: bib158 article-title: Sex differences in disease severity among patients with systemic lupus erythematosus publication-title: Gend. Med. – volume: 13 start-page: 708 year: 2014 end-page: 722 ident: bib155 article-title: Adult-onset Still's disease publication-title: Autoimmun. Rev. – year: 2020 ident: bib35 article-title: Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19 publication-title: Lancet Haematol. – volume: 395 start-page: 1771 year: 2020 end-page: 1778 ident: bib39 article-title: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study publication-title: Lancet – volume: 180 start-page: 7112 year: 2008 end-page: 7116 ident: bib150 article-title: Cutting edge: foxp3 + CD4 + CD25 + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6 publication-title: J. Immunol. – start-page: 16769 year: 2020 ident: bib33 article-title: Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review publication-title: Br. J. Haematol. – volume: 4 year: 2019 ident: bib119 article-title: Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection publication-title: JCI Insight – year: 2020 ident: bib114 article-title: Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment publication-title: MedRxiv – volume: 19 start-page: 102572 year: 2020 ident: bib179 article-title: Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms publication-title: Autoimmun. Rev. – volume: 154 start-page: 574 year: 2018 end-page: 581 ident: bib95 article-title: The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination publication-title: Immunology – volume: 4 start-page: e79 year: 2018 end-page: e82 ident: bib157 article-title: Gender differences in rheumatology and the point of view of the Italian Society for Rheumatology (SIR) publication-title: Italy J. Gender-Specific Med. – volume: 26 start-page: 453 year: 2020 end-page: 455 ident: bib109 article-title: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 publication-title: Nat. Med. – volume: 106 start-page: 879 year: 2005 end-page: 885 ident: bib91 article-title: IL-6 blocks a discrete early step in lymphopoiesis publication-title: Blood – start-page: 197 year: 2019 end-page: 207 ident: bib128 article-title: Cytokines in cytokine storm syndrome publication-title: Cytokine Storm Syndr. – volume: 203 start-page: 1021 year: 2011 end-page: 1030 ident: bib185 article-title: Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease publication-title: J. Infect. Dis. – year: 2020 ident: bib106 article-title: Mortality of COVID-19 is associated with cellular immune function compared to immune function in Chinese han population publication-title: MedRxiv – volume: 7 year: 2014 ident: bib181 article-title: Clinical and epidemiological characteristics of Kawasaki disease publication-title: Jundishapur J. Microbiol. – volume: 187 start-page: 6143 year: 2011 end-page: 6156 ident: bib55 article-title: Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus publication-title: J. Immunol. – year: 2020 ident: bib2 article-title: Coronavirus Disease 2019 (COVID-19)situation Report – 52 – volume: 11 start-page: 1 year: 2020 end-page: 7 ident: bib79 article-title: Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) publication-title: Front. Immunol. – year: 2020 ident: bib28 article-title: COVID-19 presenting with ophthalmoparesis from cranial nerve palsy publication-title: Neurology – volume: 5 year: 2020 ident: bib67 article-title: TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes publication-title: Sci. Immunol. – year: 2020 ident: bib78 article-title: An inflammatory cytokine signature helps predict COVID-19 severity and death publication-title: MedRxiv – start-page: 1 year: 2020 end-page: 23 ident: bib111 article-title: Antibody detection and dynamic characteristics in patients with COVID-19 publication-title: Clin. Infect. Dis. – volume: 26 start-page: 681 year: 2020 end-page: 687 ident: bib65 article-title: SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes publication-title: Nat. Med. – year: 2020 ident: bib49 article-title: Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact publication-title: J. Infect. – volume: 579 start-page: 270 year: 2020 end-page: 273 ident: bib110 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature – volume: 95 start-page: 100 year: 2018 end-page: 123 ident: bib10 article-title: Molecular mimicry and autoimmunity publication-title: J. Autoimmun. – volume: 55 start-page: 102763 year: 2020 ident: bib80 article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients publication-title: EBioMedicine – volume: 26 start-page: 477 year: 2012 end-page: 487 ident: bib148 article-title: Biological treatment in adult-onset Still's disease publication-title: Best Pract. Res. Clin. Rheumatol. – volume: 41 start-page: 1351 year: 2020 end-page: 1354 ident: bib27 article-title: Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital publication-title: Neurol. Sci. – year: 2020 ident: bib174 article-title: Predicting infectious SARS-CoV-2 from diagnostic samples publication-title: Clin. Infect. Dis. – year: 2020 ident: bib4 article-title: Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19 publication-title: MedRxiv – year: 2020 ident: bib112 article-title: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China publication-title: Nat. Med. – volume: 38 start-page: 337 year: 2020 end-page: 342 ident: bib192 article-title: COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? publication-title: Clin. Exp. Rheumatol. – volume: 181 start-page: 1304 year: 2019 end-page: 1306 ident: bib57 article-title: Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds publication-title: Br. J. Dermatol. – volume: 92 start-page: 512 year: 2020 end-page: 517 ident: bib171 article-title: Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses publication-title: J. Med. Virol. – year: 2020 ident: bib71 article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China publication-title: Clin. Infect. Dis. – start-page: 1 year: 2013 end-page: 4 ident: bib154 article-title: Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations publication-title: Case Rep. Med. – volume: 73 start-page: 24 year: 2014 end-page: 30 ident: bib13 article-title: Hepatitis C virus-induced vasculitis: therapeutic options publication-title: Ann. Rheum. Dis. – volume: 6 start-page: 178 year: 2004 end-page: 180 ident: bib89 article-title: Lymphopenia and autoimmune diseases publication-title: Arthritis Res. Ther. – volume: 38 start-page: J109 year: 2012 end-page: J119 ident: bib160 article-title: Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity publication-title: J. Autoimmun. – volume: 38 start-page: 373 year: 2020 end-page: 382 ident: bib190 article-title: COVID-19: the new challenge for rheumatologists publication-title: Clin. Exp. Rheumatol. – volume: 6 start-page: 56 year: 2018 ident: bib127 article-title: Cytokine release syndrome publication-title: J. Immunother. Canc. – year: 2020 ident: bib167 article-title: Reinfection could not occur in SARS-CoV-2 infected rhesus macaques publication-title: BioRxiv – volume: 9 start-page: 761 year: 2020 end-page: 770 ident: bib105 article-title: Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg publication-title: Microb. Infect. – year: 2020 ident: bib75 article-title: Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent publication-title: J. Clin. Invest. – year: 2020 ident: bib85 article-title: Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions publication-title: BioRxiv – volume: 5 start-page: 562 year: 2020 end-page: 569 ident: bib62 article-title: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses publication-title: Nat. Microbiol. – volume: 79 start-page: 668 year: 2020 end-page: 669 ident: bib136 article-title: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD publication-title: Ann. Rheum. Dis. – volume: 369 start-page: m2123 year: 2020 ident: bib186 article-title: Pediatric inflammatory syndrome temporally related to covid-19 publication-title: BMJ – year: 2020 ident: bib126 article-title: Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China publication-title: Clin. Infect. Dis. – year: 2020 ident: bib122 article-title: Early safety indicators of COVID-19 convalescent plasma in 5,000 patients publication-title: J. Clin. Invest. – volume: 11 start-page: 995 year: 2020 end-page: 998 ident: bib188 article-title: Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms publication-title: ACS Chem. Neurosci. – volume: 153 start-page: 109 year: 2010 end-page: 120 ident: bib144 article-title: Macrophage activation syndrome in autoimmune disease publication-title: Int. Arch. Allergy Immunol. – volume: 46 start-page: 846 year: 2020 end-page: 848 ident: bib3 article-title: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China publication-title: Intensive Care Med. – volume: 114 start-page: 734 year: 2017 end-page: 739 ident: bib15 article-title: Cocapture of cognate and bystander antigens can activate autoreactive B cells publication-title: Proc. Natl. Acad. Sci. Unit. States Am. – volume: 383 start-page: 1503 year: 2014 end-page: 1516 ident: bib143 article-title: Adult haemophagocytic syndrome publication-title: Lancet – volume: 28 start-page: 277 year: 2014 end-page: 292 ident: bib141 article-title: Macrophage activation syndrome and cytokine-directed therapies publication-title: Best Pract. Res. Clin. Rheumatol. – year: 2020 ident: bib47 article-title: Tocilizumab treatment in COVID-19: a single center experience publication-title: J. Med. Virol. – year: 2020 ident: bib135 article-title: Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19 publication-title: Ann. Rheum. Dis. – year: 2020 ident: bib69 article-title: Clinical Characteristics of 140 Patients Infected with SARS‐CoV‐2 in Wuhan – volume: 84 start-page: 81 year: 2005 end-page: 89 ident: bib14 article-title: Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases publication-title: Medicine (Baltim.) – year: 2020 ident: bib138 article-title: COVID-19 in rheumatic disease patients on immunosuppressive agents publication-title: Semin. Arthritis Rheum. – volume: 15 start-page: 1170 year: 2009 end-page: 1178 ident: bib54 article-title: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors publication-title: Nat. Med. – year: 2020 ident: bib97 article-title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors publication-title: MedRxiv – volume: 217 start-page: 108480 year: 2020 ident: bib177 article-title: Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases publication-title: Clin. Immunol. – volume: 34 start-page: 691 year: 2015 end-page: 698 ident: bib16 article-title: Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods publication-title: Clin. Rheumatol. – volume: 9 year: 2020 ident: bib88 article-title: Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome publication-title: Elife – volume: 395 start-page: 1607 year: 2020 end-page: 1608 ident: bib38 article-title: Hyperinflammatory shock in children during COVID-19 pandemic publication-title: Lancet – volume: 255 start-page: 5 year: 2013 end-page: 12 ident: bib142 article-title: Immunity to viruses publication-title: Immunol. Rev. – volume: 8 start-page: 959 year: 2016 end-page: 970 ident: bib129 article-title: Immunotherapeutic implications of IL-6 blockade for cytokine storm publication-title: Immunotherapy – year: 2020 ident: bib30 article-title: Autoimmune hemolytic anemia associated with Covid‐19 infection publication-title: Br. J. Haematol. – volume: 27 start-page: 992 year: 2020 end-page: 1000.e3 ident: bib133 article-title: Complex immune dysregulation in COVID-19 patients with severe respiratory failure publication-title: Cell Host Microbe – volume: 17 start-page: 935 year: 2018 end-page: 941 ident: bib52 article-title: Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory publication-title: Autoimmun. Rev. – volume: 27 start-page: 883 year: 2020 end-page: 890 ident: bib73 article-title: Heightened innate immune responses in the respiratory tract of COVID-19 patients publication-title: Cell Host Microbe – start-page: 104389 year: 2020 ident: bib61 article-title: Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach publication-title: Infect. Genet. Evol. – year: 2020 ident: bib59 article-title: Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19) publication-title: HLA – volume: 201 start-page: 1372 year: 2020 end-page: 1379 ident: bib68 article-title: Clinical features of 85 fatal cases of COVID-19 from wuhan: a retrospective observational study publication-title: Am. J. Respir. Crit. Care Med. – volume: 221 start-page: 1762 year: 2020 end-page: 1769 ident: bib102 article-title: Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia publication-title: J. Infect. Dis. – volume: 39 start-page: 2088 year: 2009 end-page: 2094 ident: bib90 article-title: Homeostatic proliferation and survival of naïve and memory T cells publication-title: Eur. J. Immunol. – volume: 39 start-page: 529 year: 2017 end-page: 539 ident: bib86 article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology publication-title: Semin. Immunopathol. – volume: 15 start-page: 547 year: 2018 end-page: 562 ident: bib187 article-title: Guillain–Barré syndrome, transverse myelitis and infectious diseases publication-title: Cell. Mol. Immunol. – volume: 395 start-page: 1033 year: 2020 end-page: 1034 ident: bib132 article-title: COVID-19: consider cytokine storm syndromes and immunosuppression publication-title: Lancet – year: 2020 ident: bib45 article-title: Lupus anticoagulant and abnormal coagulation tests in patients with covid-19 publication-title: N. Engl. J. Med. – year: 2020 ident: bib24 article-title: Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2 publication-title: J. Clin. Neurosci. – volume: 395 start-page: 1481 year: 2020 ident: bib36 article-title: Atypical presentation of COVID-19 in young infants publication-title: Lancet – volume: 117 start-page: 10970 year: 2020 end-page: 10975 ident: bib130 article-title: Effective treatment of severe COVID-19 patients with tocilizumab publication-title: Proc. Natl. Acad. Sci. Unit. States Am. – year: 2020 ident: bib113 article-title: Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France publication-title: MedRxiv – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib113 article-title: Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France publication-title: MedRxiv – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib78 article-title: An inflammatory cytokine signature helps predict COVID-19 severity and death publication-title: MedRxiv – volume: 41 start-page: 1351 issue: 6 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib27 article-title: Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital publication-title: Neurol. Sci. doi: 10.1007/s10072-020-04449-8 – volume: 13 start-page: 1562 year: 2007 ident: 10.1016/j.jaut.2020.102506_bib170 article-title: Duration of antibody responses after severe acute respiratory syndrome publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1310.070576 – volume: 7 start-page: e741 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib19 article-title: Guillain-Barré syndrome related to COVID-19 infection publication-title: Neurol. Neuroimmunol. Neuroinflammation. doi: 10.1212/NXI.0000000000000741 – volume: 15 start-page: 547 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib187 article-title: Guillain–Barré syndrome, transverse myelitis and infectious diseases publication-title: Cell. Mol. Immunol. doi: 10.1038/cmi.2017.142 – volume: 16 start-page: 47 year: 2015 ident: 10.1016/j.jaut.2020.102506_bib194 article-title: Genetics and vaccines in the era of personalized medicine publication-title: Curr. Genom. doi: 10.2174/1389202916666141223220551 – volume: 395 start-page: 1339 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib173 article-title: SARS-CoV-2 shedding and infectivity publication-title: Lancet doi: 10.1016/S0140-6736(20)30868-0 – year: 2010 ident: 10.1016/j.jaut.2020.102506_bib149 article-title: Tocilizumab for rheumatoid arthritis – volume: 7 year: 2014 ident: 10.1016/j.jaut.2020.102506_bib181 article-title: Clinical and epidemiological characteristics of Kawasaki disease publication-title: Jundishapur J. Microbiol. doi: 10.5812/jjm.11014 – volume: 27 start-page: 992 issue: 10 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib133 article-title: Complex immune dysregulation in COVID-19 patients with severe respiratory failure publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.04.009 – volume: 9 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib88 article-title: Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome publication-title: Elife doi: 10.7554/eLife.57555 – volume: 19 start-page: 102554 issue: 7 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib121 article-title: Convalescent plasma in Covid-19: possible mechanisms of action publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2020.102554 – volume: 46 start-page: 1089 issue: 6 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib46 article-title: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study publication-title: Intensive Care Med. doi: 10.1007/s00134-020-06062-x – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib49 article-title: Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact publication-title: J. Infect. doi: 10.1016/j.jinf.2020.04.017 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib85 article-title: Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions publication-title: BioRxiv – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib23 article-title: Guillain‐Barre syndrome during SARS‐CoV ‐2 pandemic: a case report and review of recent literature publication-title: J. Peripher. Nerv. Syst. doi: 10.1111/jns.12382 – volume: 27 start-page: 883 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib73 article-title: Heightened innate immune responses in the respiratory tract of COVID-19 patients publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.04.017 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib120 article-title: Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools publication-title: Virol. Sin. doi: 10.1007/s12250-020-00207-4 – volume: 317 start-page: 121 issue: 80- year: 2007 ident: 10.1016/j.jaut.2020.102506_bib162 article-title: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production publication-title: Science doi: 10.1126/science.1140485 – volume: 181 start-page: 271 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib66 article-title: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor publication-title: Cell doi: 10.1016/j.cell.2020.02.052 – volume: 187 start-page: 6143 year: 2011 ident: 10.1016/j.jaut.2020.102506_bib55 article-title: Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus publication-title: J. Immunol. doi: 10.4049/jimmunol.1101284 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib122 article-title: Early safety indicators of COVID-19 convalescent plasma in 5,000 patients publication-title: J. Clin. Invest. doi: 10.1172/JCI140200 – volume: 3 start-page: e297 year: 2006 ident: 10.1016/j.jaut.2020.102506_bib50 article-title: A proposed classification of the immunological diseases publication-title: PLoS Med. doi: 10.1371/journal.pmed.0030297 – volume: 37 start-page: 2305 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib53 article-title: From autoinflammation to autoimmunity: old and recent findings publication-title: Clin. Rheumatol. doi: 10.1007/s10067-018-4209-9 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib59 article-title: Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19) publication-title: HLA doi: 10.1111/tan.13941 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib83 article-title: Disruption of the CCL5/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19 publication-title: MedRxiv – volume: 6 start-page: 56 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib127 article-title: Cytokine release syndrome publication-title: J. Immunother. Canc. doi: 10.1186/s40425-018-0343-9 – volume: 26 start-page: 477 year: 2012 ident: 10.1016/j.jaut.2020.102506_bib148 article-title: Biological treatment in adult-onset Still's disease publication-title: Best Pract. Res. Clin. Rheumatol. doi: 10.1016/j.berh.2012.07.002 – volume: 11 start-page: 762 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib9 article-title: Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms publication-title: Viruses doi: 10.3390/v11080762 – volume: 95 start-page: 183 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib70 article-title: Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2020.03.013 – volume: 103 start-page: 102301 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib11 article-title: Bystander activation and autoimmunity publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2019.06.012 – volume: 69 start-page: 1135 year: 2017 ident: 10.1016/j.jaut.2020.102506_bib125 article-title: Review: cytokine storm syndrome: looking toward the precision medicine era publication-title: Arthritis Rheum. doi: 10.1002/art.40071 – volume: 15 start-page: R39 year: 2013 ident: 10.1016/j.jaut.2020.102506_bib153 article-title: Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease publication-title: Arthritis Res. Ther. doi: 10.1186/ar4193 – volume: 176 start-page: 7278 year: 2006 ident: 10.1016/j.jaut.2020.102506_bib147 article-title: IL-1β breaks tolerance through expansion of CD25 + effector T cells publication-title: J. Immunol. doi: 10.4049/jimmunol.176.12.7278 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib118 article-title: Analysis of a SARS-CoV-2 infected individual reveals development of potent neutralizing antibodies to distinct epitopes with limited somatic mutation publication-title: Immunity doi: 10.1016/j.immuni.2020.06.001 – volume: 55 start-page: 102763 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib80 article-title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients publication-title: EBioMedicine doi: 10.1016/j.ebiom.2020.102763 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib60 article-title: The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis publication-title: MedRxiv – volume: 108 start-page: 335 year: 2001 ident: 10.1016/j.jaut.2020.102506_bib94 article-title: T cell homeostasis and systemic autoimmunity publication-title: J. Clin. Invest. doi: 10.1172/JCI200112173 – volume: 8 start-page: 365 year: 2011 ident: 10.1016/j.jaut.2020.102506_bib158 article-title: Sex differences in disease severity among patients with systemic lupus erythematosus publication-title: Gend. Med. doi: 10.1016/j.genm.2011.10.003 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib140 article-title: Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in Northern Italy: a telemedicine study publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2020.05.047 – volume: 15 start-page: 458 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib104 article-title: When worlds collide: Th17 and Treg cells in cancer and autoimmunity publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-018-0004-4 – volume: 395 start-page: 497 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib123 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 – volume: 8 start-page: 152 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib165 article-title: Gender differences in patients with COVID-19: focus on severity and mortality publication-title: Front. Public. Health doi: 10.3389/fpubh.2020.00152 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib167 article-title: Reinfection could not occur in SARS-CoV-2 infected rhesus macaques publication-title: BioRxiv – volume: 38 start-page: 337 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib192 article-title: COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? publication-title: Clin. Exp. Rheumatol. doi: 10.55563/clinexprheumatol/xcdary – volume: 84 start-page: 81 year: 2005 ident: 10.1016/j.jaut.2020.102506_bib14 article-title: Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases publication-title: Medicine (Baltim.) doi: 10.1097/01.md.0000157397.30055.c9 – start-page: 1 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib131 – volume: 382 start-page: e38 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib43 article-title: Coagulopathy and antiphospholipid antibodies in patients with covid-19 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2007575 – volume: 20 start-page: 363 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib6 article-title: The trinity of COVID-19: immunity, inflammation and intervention publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-020-0311-8 – volume: 215 start-page: 108426 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib176 article-title: On the molecular determinants of the SARS-CoV-2 attack publication-title: Clin. Immunol. doi: 10.1016/j.clim.2020.108426 – volume: 10 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib145 article-title: The immunology of macrophage activation syndrome publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.00119 – volume: 395 start-page: 1481 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib36 article-title: Atypical presentation of COVID-19 in young infants publication-title: Lancet doi: 10.1016/S0140-6736(20)30980-6 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib35 article-title: Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19 publication-title: Lancet Haematol. doi: 10.1016/S2352-3026(20)30175-7 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib41 article-title: Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.048360 – volume: 117 start-page: 10970 issue: 20 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib130 article-title: Effective treatment of severe COVID-19 patients with tocilizumab publication-title: Proc. Natl. Acad. Sci. Unit. States Am. doi: 10.1073/pnas.2005615117 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib2 – volume: 31 start-page: 781 year: 2011 ident: 10.1016/j.jaut.2020.102506_bib151 article-title: The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus publication-title: J. Interferon Cytokine Res. doi: 10.1089/jir.2011.0047 – volume: 14 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib182 article-title: Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group publication-title: PloS One doi: 10.1371/journal.pone.0215665 – volume: 13 start-page: 708 year: 2014 ident: 10.1016/j.jaut.2020.102506_bib155 article-title: Adult-onset Still's disease publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2014.01.058 – volume: 141 start-page: 381 year: 2005 ident: 10.1016/j.jaut.2020.102506_bib183 article-title: Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2005.02821.x – start-page: 16769 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib33 article-title: Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review publication-title: Br. J. Haematol. – year: 2013 ident: 10.1016/j.jaut.2020.102506_bib58 – volume: 382 start-page: 727 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib1 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2001017 – volume: 6 start-page: 178 year: 2004 ident: 10.1016/j.jaut.2020.102506_bib89 article-title: Lymphopenia and autoimmune diseases publication-title: Arthritis Res. Ther. doi: 10.1186/ar1208 – volume: 10 start-page: 1 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib146 article-title: Signaling through gp130 compromises suppressive function in human FOXP3+ regulatory T cells publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01532 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib8 article-title: Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis publication-title: J. Med. Virol. doi: 10.1002/jmv.25866 – volume: 203 start-page: 1021 year: 2011 ident: 10.1016/j.jaut.2020.102506_bib185 article-title: Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiq136 – start-page: 1 year: 2013 ident: 10.1016/j.jaut.2020.102506_bib154 article-title: Adult onset Still's disease: a case report with a rare clinical manifestation and pathophysiological correlations publication-title: Case Rep. Med. doi: 10.1155/2013/981232 – volume: 1 start-page: 45 year: 2015 ident: 10.1016/j.jaut.2020.102506_bib161 article-title: Sex hormones and gender disparity in immunity and autoimmunity publication-title: Italy J. Gender-Specifi c Med. – volume: 47 start-page: 764 year: 1988 ident: 10.1016/j.jaut.2020.102506_bib18 article-title: Adult onset Still's disease and viral infections publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.47.9.764 – volume: 17 start-page: 533 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib72 article-title: Functional exhaustion of antiviral lymphocytes in COVID-19 patients publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-020-0402-2 – volume: 19 start-page: 102556 issue: 7 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib175 article-title: Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2020.102556 – volume: 8 start-page: 959 year: 2016 ident: 10.1016/j.jaut.2020.102506_bib129 article-title: Immunotherapeutic implications of IL-6 blockade for cytokine storm publication-title: Immunotherapy doi: 10.2217/imt-2016-0020 – volume: 395 start-page: 1607 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib38 article-title: Hyperinflammatory shock in children during COVID-19 pandemic publication-title: Lancet doi: 10.1016/S0140-6736(20)31094-1 – volume: 815 start-page: 334 year: 1997 ident: 10.1016/j.jaut.2020.102506_bib17 article-title: Herpes viruses in multicase families with rheumatoid arthritis and systemic lupus erythematosus publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1997.tb52078.x – volume: 39 start-page: 196 year: 2017 ident: 10.1016/j.jaut.2020.102506_bib156 article-title: Gender Medicine: a interdisciplinary approach to medicine publication-title: G. Ital. Med. Lav. Ergon. – volume: 39 start-page: 2088 year: 2009 ident: 10.1016/j.jaut.2020.102506_bib90 article-title: Homeostatic proliferation and survival of naïve and memory T cells publication-title: Eur. J. Immunol. doi: 10.1002/eji.200939444 – volume: 38 start-page: J109 year: 2012 ident: 10.1016/j.jaut.2020.102506_bib160 article-title: Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2011.10.003 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib37 article-title: COVID-19 and Kawasaki disease: novel virus and novel case publication-title: Hosp. Pediatr. doi: 10.1542/hpeds.2020-0123 – volume: 217 start-page: 108480 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib177 article-title: Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases publication-title: Clin. Immunol. doi: 10.1016/j.clim.2020.108480 – volume: 28 start-page: 621 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib98 article-title: CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients publication-title: Lupus doi: 10.1177/0961203319838063 – volume: 369 start-page: m2123 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib186 article-title: Pediatric inflammatory syndrome temporally related to covid-19 publication-title: BMJ doi: 10.1136/bmj.m2123 – volume: 153 start-page: 109 year: 2010 ident: 10.1016/j.jaut.2020.102506_bib144 article-title: Macrophage activation syndrome in autoimmune disease publication-title: Int. Arch. Allergy Immunol. doi: 10.1159/000312628 – volume: 213 start-page: 904 year: 2016 ident: 10.1016/j.jaut.2020.102506_bib107 article-title: Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiv380 – volume: 5 start-page: 33 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib92 article-title: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study publication-title: Signal Transduct. Target. Theroy doi: 10.1038/s41392-020-0148-4 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib22 article-title: Guillain-Barré syndrome as a complication of SARS-CoV-2 infection publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2020.04.074 – volume: 58 start-page: 71 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib152 article-title: Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease publication-title: Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-019-08747-8 – volume: 12 start-page: 22 year: 2012 ident: 10.1016/j.jaut.2020.102506_bib51 article-title: Autoinflammation and autoimmunity: bridging the divide publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2012.07.018 – volume: 12 start-page: 282 year: 2012 ident: 10.1016/j.jaut.2020.102506_bib56 article-title: Integration of B cell responses through Toll-like receptors and antigen receptors publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3190 – volume: 229 start-page: 173 year: 2009 ident: 10.1016/j.jaut.2020.102506_bib99 article-title: The significance of OX40 and OX40L to T-cell biology and immune disease publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2009.00766.x – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib77 article-title: Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury publication-title: Natl. Sci. Rev. – volume: 26 start-page: 453 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib109 article-title: Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0819-2 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib24 article-title: Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2 publication-title: J. Clin. Neurosci. doi: 10.1016/j.jocn.2020.05.016 – volume: 323 start-page: 2249 issue: 22 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib5 article-title: Interpreting diagnostic tests for SARS-CoV-2 publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.2020.8259 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib81 article-title: Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China publication-title: MedRxiv – volume: 131 start-page: 1652 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib25 article-title: Post SARS-CoV-2 guillain-barré syndrome publication-title: Clin. Neurophysiol. doi: 10.1016/j.clinph.2020.05.003 – volume: 46 start-page: 846 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib3 article-title: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China publication-title: Intensive Care Med. doi: 10.1007/s00134-020-05991-x – volume: 86 start-page: 4234 year: 2012 ident: 10.1016/j.jaut.2020.102506_bib168 article-title: Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge publication-title: J. Virol. doi: 10.1128/JVI.06791-11 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib137 article-title: Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2020-217549 – volume: 30 start-page: 121 year: 2011 ident: 10.1016/j.jaut.2020.102506_bib159 article-title: Spondyloarthritis in women: differences in disease onset, clinical presentation, and Bath Ankylosing Spondylitis Disease Activity and Functional indices (BASDAI and BASFI) between men and women with spondyloarthritides publication-title: Clin. Rheumatol. doi: 10.1007/s10067-010-1581-5 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib26 article-title: Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 publication-title: Neurology doi: 10.1212/WNL.0000000000009619 – volume: 109 start-page: 102442 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib193 article-title: Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2020.102442 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib71 article-title: Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa248 – volume: 579 start-page: 270 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib110 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature doi: 10.1038/s41586-020-2012-7 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib174 article-title: Predicting infectious SARS-CoV-2 from diagnostic samples publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa638 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib69 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib189 article-title: Cranial neuropathies and COVID-19: neurotropism and autoimmunity publication-title: Neurology doi: 10.1212/WNL.0000000000009921 – volume: 180 start-page: 7112 year: 2008 ident: 10.1016/j.jaut.2020.102506_bib150 article-title: Cutting edge: foxp3 + CD4 + CD25 + regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6 publication-title: J. Immunol. doi: 10.4049/jimmunol.180.11.7112 – volume: 5 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib67 article-title: TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abc3582 – volume: 109 start-page: 4882 year: 2007 ident: 10.1016/j.jaut.2020.102506_bib100 article-title: CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype publication-title: Blood doi: 10.1182/blood-2006-10-043463 – start-page: 1 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib111 article-title: Antibody detection and dynamic characteristics in patients with COVID-19 publication-title: Clin. Infect. Dis. – volume: 79 start-page: 668 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib136 article-title: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2020-217442 – volume: 11 start-page: 1 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib79 article-title: Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) publication-title: Front. Immunol. doi: 10.3389/fimmu.2020.00827 – volume: 26 start-page: 681 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib65 article-title: SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes publication-title: Nat. Med. doi: 10.1038/s41591-020-0868-6 – volume: 28 start-page: 277 year: 2014 ident: 10.1016/j.jaut.2020.102506_bib141 article-title: Macrophage activation syndrome and cytokine-directed therapies publication-title: Best Pract. Res. Clin. Rheumatol. doi: 10.1016/j.berh.2014.03.002 – volume: 57 start-page: 2863 year: 2008 ident: 10.1016/j.jaut.2020.102506_bib12 article-title: Viral trigger for type 1 diabetes: pros and cons publication-title: Diabetes doi: 10.2337/db07-1023 – volume: 5 start-page: 562 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib62 article-title: Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses publication-title: Nat. Microbiol. doi: 10.1038/s41564-020-0688-y – volume: 383 start-page: 1503 year: 2014 ident: 10.1016/j.jaut.2020.102506_bib143 article-title: Adult haemophagocytic syndrome publication-title: Lancet doi: 10.1016/S0140-6736(13)61048-X – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib134 article-title: Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2020-217362 – volume: 130 start-page: 2757 issue: 6 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib117 article-title: Deployment of convalescent plasma for the prevention and treatment of COVID-19 publication-title: J. Clin. Invest. doi: 10.1172/JCI138745 – volume: 9 start-page: 45 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib63 article-title: Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues publication-title: Infect. Disease Poverty. doi: 10.1186/s40249-020-00662-x – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib172 – volume: 181 start-page: 1036 issue: 5 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib76 article-title: Imbalanced host response to SARS-CoV-2 drives development of COVID-19 publication-title: Cell doi: 10.1016/j.cell.2020.04.026 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib106 article-title: Mortality of COVID-19 is associated with cellular immune function compared to immune function in Chinese han population publication-title: MedRxiv – volume: 17 start-page: 1 year: 2002 ident: 10.1016/j.jaut.2020.102506_bib103 article-title: Autoreactive CD8 T cells in organ-specific autoimmunity publication-title: Immunity doi: 10.1016/S1074-7613(02)00338-2 – volume: 382 start-page: e43 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib29 article-title: Immune thrombocytopenic purpura in a patient with covid-19 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2010472 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib64 article-title: Multiorgan and renal tropism of SARS-CoV-2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2011400 – volume: 255 start-page: 5 year: 2013 ident: 10.1016/j.jaut.2020.102506_bib142 article-title: Immunity to viruses publication-title: Immunol. Rev. doi: 10.1111/imr.12109 – volume: 92 start-page: 512 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib171 article-title: Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses publication-title: J. Med. Virol. doi: 10.1002/jmv.25715 – volume: 95 start-page: 100 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib10 article-title: Molecular mimicry and autoimmunity publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2018.10.012 – volume: 369 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib42 article-title: Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study publication-title: BMJ – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib47 article-title: Tocilizumab treatment in COVID-19: a single center experience publication-title: J. Med. Virol. doi: 10.1002/jmv.25801 – volume: 4 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib119 article-title: Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection publication-title: JCI Insight doi: 10.1172/jci.insight.123158 – volume: 181 start-page: 1304 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib57 article-title: Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds publication-title: Br. J. Dermatol. doi: 10.1111/bjd.18203 – volume: 8 start-page: 420 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib101 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(20)30076-X – volume: 39 start-page: 529 year: 2017 ident: 10.1016/j.jaut.2020.102506_bib86 article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology publication-title: Semin. Immunopathol. doi: 10.1007/s00281-017-0629-x – start-page: 197 year: 2019 ident: 10.1016/j.jaut.2020.102506_bib128 article-title: Cytokines in cytokine storm syndrome – volume: 4 start-page: e79 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib157 article-title: Gender differences in rheumatology and the point of view of the Italian Society for Rheumatology (SIR) publication-title: Italy J. Gender-Specific Med. – volume: 395 start-page: 1771 issue: 10239 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib39 article-title: An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)31103-X – volume: 30 start-page: 313 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib48 article-title: Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19) publication-title: J. Microbiol. Biotechnol. doi: 10.4014/jmb.2003.03011 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib75 article-title: Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent publication-title: J. Clin. Invest. doi: 10.1172/JCI138554 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib7 article-title: Antibody responses to SARS-CoV-2 in patients with COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0897-1 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib20 article-title: Guillain–barré syndrome associated with SARS-CoV-2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2009191 – volume: 201 start-page: 1372 issue: 11 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib68 article-title: Clinical features of 85 fatal cases of COVID-19 from wuhan: a retrospective observational study publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.202003-0543OC – volume: 57 start-page: 12 year: 2013 ident: 10.1016/j.jaut.2020.102506_bib96 article-title: Autoimmune effector memory T cells: the bad and the good publication-title: Immunol. Res. doi: 10.1007/s12026-013-8448-1 – volume: 395 start-page: 1033 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib132 article-title: COVID-19: consider cytokine storm syndromes and immunosuppression publication-title: Lancet doi: 10.1016/S0140-6736(20)30628-0 – start-page: 1 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib87 article-title: COVID-19: the vasculature unleashed publication-title: Nat. Rev. Immunol. – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib180 article-title: Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases publication-title: Br. J. Dermatol. doi: 10.1111/bjd.19163 – volume: 43 start-page: 317 year: 2010 ident: 10.1016/j.jaut.2020.102506_bib184 article-title: Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease publication-title: Autoimmunity doi: 10.3109/08916930903405891 – start-page: 104389 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib61 article-title: Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach publication-title: Infect. Genet. Evol. doi: 10.1016/j.meegid.2020.104389 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib40 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib74 article-title: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients publication-title: Natl. Sci. Rev. – volume: 221 start-page: 1762 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib102 article-title: Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiaa150 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib34 article-title: COVID-19-associated immune thrombocytopenia publication-title: Br. J. Haematol. doi: 10.1111/bjh.16850 – start-page: 26138 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib32 article-title: COVID‐19 presenting with immune thrombocytopenia: a case report and review of the literature publication-title: J. Med. Virol. doi: 10.1002/jmv.26138 – volume: 19 start-page: 102572 issue: 7 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib179 article-title: Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2020.102572 – volume: 93 start-page: 297 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib169 article-title: Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report publication-title: Int. J. Infect. Dis. doi: 10.1016/j.ijid.2020.03.003 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib28 article-title: COVID-19 presenting with ophthalmoparesis from cranial nerve palsy publication-title: Neurology – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib82 article-title: Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome publication-title: MedRxiv – volume: 17 start-page: 935 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib52 article-title: Nature versus nurture in the spectrum of rheumatic diseases: classification of spondyloarthritis as autoimmune or autoinflammatory publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2018.04.002 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib97 article-title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors publication-title: MedRxiv – volume: 6 start-page: 49 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib164 article-title: Gender differences in COVID-19: some open questions publication-title: Italy. J. Gender-Specific Med. – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib138 article-title: COVID-19 in rheumatic disease patients on immunosuppressive agents publication-title: Semin. Arthritis Rheum. doi: 10.1016/j.semarthrit.2020.05.010 – volume: 15 start-page: 1170 year: 2009 ident: 10.1016/j.jaut.2020.102506_bib54 article-title: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors publication-title: Nat. Med. doi: 10.1038/nm.2028 – volume: 114 start-page: 734 year: 2017 ident: 10.1016/j.jaut.2020.102506_bib15 article-title: Cocapture of cognate and bystander antigens can activate autoreactive B cells publication-title: Proc. Natl. Acad. Sci. Unit. States Am. doi: 10.1073/pnas.1614472114 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib135 article-title: Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19 publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2020-217562 – volume: 106 start-page: 879 year: 2005 ident: 10.1016/j.jaut.2020.102506_bib91 article-title: IL-6 blocks a discrete early step in lymphopoiesis publication-title: Blood doi: 10.1182/blood-2005-02-0456 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib115 article-title: Rapid generation of neutralizing antibody responses in COVID-19 patients publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2020.100040 – volume: 9 start-page: 761 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib105 article-title: Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients, Emerg publication-title: Microb. Infect. – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib30 article-title: Autoimmune hemolytic anemia associated with Covid‐19 infection publication-title: Br. J. Haematol. doi: 10.1111/bjh.16794 – volume: 11 start-page: 995 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib188 article-title: Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.0c00122 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib4 article-title: Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19 publication-title: MedRxiv – volume: 5 start-page: 305 year: 2013 ident: 10.1016/j.jaut.2020.102506_bib178 article-title: Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease publication-title: Ther. Adv. Musculoskelet. Disease doi: 10.1177/1759720X13502919 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib126 article-title: Clinical features of 69 cases with coronavirus disease 2019 in wuhan, China publication-title: Clin. Infect. Dis. – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib45 article-title: Lupus anticoagulant and abnormal coagulation tests in patients with covid-19 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2013656 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib112 article-title: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China publication-title: Nat. Med. – start-page: 2 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib108 article-title: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion publication-title: Cell. Mol. Immunol. – volume: 177 start-page: 104762 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib191 article-title: Of chloroquine and COVID-19 publication-title: Antivir. Res. doi: 10.1016/j.antiviral.2020.104762 – volume: 19 start-page: 102575 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib139 article-title: SARS-CoV-2 infection among patients with systemic autoimmune diseases publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2020.102575 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib44 article-title: Lupus anticoagulant is frequent in patients with Covid‐19 publication-title: J. Thromb. Haemostasis – volume: 154 start-page: 574 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib95 article-title: The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination publication-title: Immunology doi: 10.1111/imm.12929 – volume: 15 start-page: 206 year: 2018 ident: 10.1016/j.jaut.2020.102506_bib163 article-title: The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation publication-title: J. Neuroinflammation doi: 10.1186/s12974-018-1246-x – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib114 article-title: Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment publication-title: MedRxiv – volume: 7 year: 2012 ident: 10.1016/j.jaut.2020.102506_bib166 article-title: Lack of innate Interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model publication-title: PloS One doi: 10.1371/journal.pone.0045842 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib31 article-title: Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia publication-title: Br. J. Haematol. doi: 10.1111/bjh.16786 – volume: 53 start-page: 368 issue: 3 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib124 article-title: TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib publication-title: J. Microbiol. Immunol. Infect. doi: 10.1016/j.jmii.2020.03.005 – volume: 98 start-page: 23 year: 2005 ident: 10.1016/j.jaut.2020.102506_bib93 article-title: A causal link between lymphopenia and autoimmunity publication-title: Immunol. Lett. doi: 10.1016/j.imlet.2004.10.022 – ident: 10.1016/j.jaut.2020.102506_bib84 – volume: 20 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib21 article-title: Guillain-Barré Syndrome associated with SARS-CoV-2 infection publication-title: IDCases doi: 10.1016/j.idcr.2020.e00771 – volume: 38 start-page: 373 issue: 3 year: 2020 ident: 10.1016/j.jaut.2020.102506_bib190 article-title: COVID-19: the new challenge for rheumatologists publication-title: Clin. Exp. Rheumatol. – volume: 73 start-page: 24 year: 2014 ident: 10.1016/j.jaut.2020.102506_bib13 article-title: Hepatitis C virus-induced vasculitis: therapeutic options publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2013-203883 – year: 2020 ident: 10.1016/j.jaut.2020.102506_bib116 article-title: Convergent antibody responses to SARS-CoV-2 infection in convalescent individuals publication-title: BioRxiv – volume: 34 start-page: 691 year: 2015 ident: 10.1016/j.jaut.2020.102506_bib16 article-title: Correlation between systemic lupus erythematosus and cytomegalovirus infection detected by different methods publication-title: Clin. Rheumatol. doi: 10.1007/s10067-015-2868-3 |
SSID | ssj0011555 |
Score | 2.6599784 |
SecondaryResourceType | review_article |
Snippet | Coronavirus disease 2019 (COVID-19) has been categorized as evolving in overlapping phases. First, there is a viral phase that may well be asymptomatic or mild... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 102506 |
SubjectTerms | Adaptive Immunity - genetics Antiphospholipid syndrome Autoimmune Diseases - diagnosis Autoimmune Diseases - immunology Autoimmune Diseases - therapy Autoimmune Diseases - virology Autoimmunity Betacoronavirus - immunology Betacoronavirus - isolation & purification Clinical Laboratory Techniques Coronavirus Infections - diagnosis Coronavirus Infections - epidemiology Coronavirus Infections - immunology Coronavirus Infections - therapy COVID-19 COVID-19 Testing Critical Illness Cytokine Release Syndrome - diagnosis Cytokine Release Syndrome - immunology Cytokine Release Syndrome - therapy Cytokine Release Syndrome - virology Cytokine storm syndrome Cytopenia Female Genetic Predisposition to Disease Guillain-Barré syndrome Humans Immunity, Innate - genetics Immunization, Passive - methods Inflammation Mediators - blood Inflammation Mediators - immunology Kawasaki disease Macrophage Activation - genetics Macrophage Activation - immunology Male Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - epidemiology Pneumonia, Viral - immunology Pneumonia, Viral - therapy Risk Factors SARS-CoV-2 Severity of Illness Index Sex Factors Vaccines |
Title | Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0896841120301281 https://dx.doi.org/10.1016/j.jaut.2020.102506 https://www.ncbi.nlm.nih.gov/pubmed/32563547 https://www.proquest.com/docview/2415836476 https://pubmed.ncbi.nlm.nih.gov/PMC7296326 |
Volume | 114 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9RADLaqoiIuFZRHt0A1SNxQ2E3ibCbH1ULZgloOUNTbaF5Rt2qTqs0eeuG3Y2eSiAVUpB4zsaWJ7XE-a_wAeJtYianMfeStLyM0lo4UJpqcoS3JZkzhYq5GPjqeLk7w82l2ugHzvhaG0yo73x98euutu5VxJ83x1XI5_jaRxVQi4QVG9Ulbfo2Ys5W__zmkeRDgaSefMnHE1F3hTMjxOucsEQr_2w4GGU89-vfP6W_w-WcO5W8_pYPHsN2hSTELG34CG77aga0wX_J2Bx4edTfnT-HTbNXUZE1kAJftxbrQlROaF7lCxAuKi11I3xK6EQQLRdhjrZ2oSzH_-uPwQxQXz-Dk4OP3-SLqhihENsuTJirRxJY-LSfoIk1mJqhTpChG5lLbJHakEulTLAxyaz0n0WSJcc4WUywsKSF9DptVXfldENw53plCJh41lhRYxilOtDeGdJqhdyOIe-kp23UY50EXF6pPJTtXLHHFEldB4iN4N_Bchf4ad1KnvVJUXzlKvk6R-7-TKxu41mzrv3xver0rOnR8k6IrX69uFMMeyZ33ieZFsINh9ymByDTDfAT5moUMBNzQe_1NtTxrG3tToDMlOL13z_2-hEf8FColX8Fmc73yrwkyNWa_PRP78GB2-GVx_As9vhSA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCaKFN16GdbulT01oLfBSGzLsXwMsnVJ26SHtkNvgl5GU2x20TmH_fuRkWw03dABu1oiIJMU9QkiPwIcJEbwVOQucsaVEdcGtxRPFAZDU6LP6MLGVI08X4ymF_zoMrvcgklbC0NplSH2-5i-jtbhyyBoc3CzXA7OhqIYCY54gVB9QuXX28ROlfVgezw7ni66xwQ8MteZjDg_IoFQO-PTvK4pUSRB0EQkBhk1Pvr7-fQn_ryfRnnnXDp8Ck8CoGRjv-Y92HLVPuz4FpO_9uHRPDyeP4Ov41VTo0OhD_xYv60zVVmm6CMViTiGV2PrM7iYahgiQ-bXWCvL6pJNTr_NPkdx8RwuDr-cT6ZR6KMQmSxPmqjkOjb4azmiF6EzPeQq5XiREblQJoktWkW4lBeaE7ueFVxnibbWFCNeGLRD-gJ6VV25V8CIPN7qQiSOK17i3TJO-VA5rdGsGXe2D3GrPWkCyTj1uvgu22yya0kal6Rx6TXeh0-dzI2n2HhwdtoaRbbFoxjuJJ4AD0plndSGe_1T7mNrd4n7jh5TVOXq1U9JyEcQ-T7Oeen9oFt9ijgyRVfsQ77hId0E4vTeHKmWV2tub7zrjBBRv_7P9X6Ax9Pz-Yk8mS2O38AujfjCybfQa25X7h0iqEa_DzvkN6zZFzE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autoinflammatory+and+autoimmune+conditions+at+the+crossroad+of+COVID-19&rft.jtitle=Journal+of+autoimmunity&rft.au=Rodr%C3%ADguez%2C+Yhojan&rft.au=Novelli%2C+Lucia&rft.au=Rojas%2C+Manuel&rft.au=De+Santis%2C+Maria&rft.date=2020-11-01&rft.eissn=1095-9157&rft.volume=114&rft.spage=102506&rft_id=info:doi/10.1016%2Fj.jaut.2020.102506&rft_id=info%3Apmid%2F32563547&rft.externalDocID=32563547 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-8411&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-8411&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-8411&client=summon |